P673 DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS B (Englisch)
- Neue Suche nach: Otero-Fernández, M.
- Neue Suche nach: Llorca, R.
- Neue Suche nach: Ampuero, J.
- Neue Suche nach: Martinez-Alcala, A.
- Neue Suche nach: Vargas-Perez, M.
- Neue Suche nach: Vargas-Romero, J.
- Neue Suche nach: Cortes, M.
- Neue Suche nach: Romero-Gomez, M.
- Neue Suche nach: Otero-Fernández, M.
- Neue Suche nach: Llorca, R.
- Neue Suche nach: Ampuero, J.
- Neue Suche nach: Martinez-Alcala, A.
- Neue Suche nach: Vargas-Perez, M.
- Neue Suche nach: Vargas-Romero, J.
- Neue Suche nach: Cortes, M.
- Neue Suche nach: Romero-Gomez, M.
In:
JOURNAL OF HEPATOLOGY
;
60
, 1
;
S293
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P673 DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS B
-
Beteiligte:Otero-Fernández, M. ( Autor:in ) / Llorca, R. ( Autor:in ) / Ampuero, J. ( Autor:in ) / Martinez-Alcala, A. ( Autor:in ) / Vargas-Perez, M. ( Autor:in ) / Vargas-Romero, J. ( Autor:in ) / Cortes, M. ( Autor:in ) / Romero-Gomez, M. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 60, 1 ; S293
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2014
-
Format / Umfang:S293
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 60, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
FocusFriedman, S. L. et al. | 2014
- 3
-
Journal of Hepatology, an international top rank journalSamuel, D. et al. | 2014
- 4
-
Go EastPeck-Radosavljevic, M. et al. | 2014
- 6
-
Victory and defeat at Heraclea – Treating hepatitis C infection following liver transplantation with telaprevir and boceprevirCharlton, M. / Dick, T. et al. | 2014
- 9
-
Hepatic CD141+IFNλ+ DC subset: One against all?Wegscheid, C. / Karimi, K. / Tiegs, G. et al. | 2014
- 12
-
Time to say goodbye to the drug or the model? – Why do drugs fail to live up to their promise in bile duct ligated mice?Fickert, P. et al. | 2014
- 16
-
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirinAndriulli, A. / Di Marco, V. / Margaglione, M. / Ippolito, A. M. / Fattovich, G. / Smedile, A. / Valvano, M. R. / Calvaruso, V. / Gioffreda, D. / Milella, M. et al. | 2014
- 22
-
HLA-B⁎27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitopeNitschke, K. / Barriga, A. / Schmidt, J. / Timm, J. r. / Viazov, S. / Kuntzen, T. / Kim, A. Y. / Lauer, G. M. / Allen, T. M. / Gaudieri, S. et al. | 2014
- 30
-
Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1α activityFoka, P. / Karamichali, E. / Dalagiorgou, G. / Serti, E. / Doumba, P. P. / Pissas, G. / Kakkanas, A. / Kazazi, D. / Kochlios, E. / Gaitanou, M. et al. | 2014
- 39
-
Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disordersFransen van de Putte, D. E. / Makris, M. / Fischer, K. / Yee, T. T. / Kirk, L. / van Erpecum, K. J. / Patch, D. / Posthouwer, D. / Mauser-Bunschoten, E. P. et al. | 2014
- 46
-
Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort studyCarrieri, M. P. / Lions, C. / Sogni, P. / Winnock, M. / Roux, P. / Mora, M. / Bonnard, P. / Salmon, D. / Dabis, F. o. / Spire, B. et al. | 2014
- 54
-
Reduction of HBV replication prolongs the early immunological response to IFNα therapyTan, A. T. / Hoang, L. T. / Chin, D. / Rasmussen, E. / Lopatin, U. / Hart, S. / Bitter, H. / Chu, T. / Gruenbaum, L. / Ravindran, P. et al. | 2014
- 62
-
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapyPapatheodoridis, G. / Goulis, J. / Manolakopoulos, S. / Margariti, A. / Exarchos, X. / Kokkonis, G. / Hadziyiannis, E. / Papaioannou, C. / Manesis, E. / Pectasides, D. et al. | 2014
- 69
-
Multiparametric magnetic resonance for the non-invasive diagnosis of liver diseaseBanerjee, R. / Pavlides, M. / Tunnicliffe, E. M. / Piechnik, S. K. / Sarania, N. / Philips, R. / Collier, J. D. / Booth, J. C. / Schneider, J. E. / Wang, L. M. et al. | 2014
- 78
-
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experienceCoilly, A. / Roche, B. / Dumortier, J. r. / Leroy, V. / Botta-Fridlund, D. / Radenne, S. / Pageaux, G. P. / Si-Ahmed, S. N. / Guillaud, O. / Antonini, T. M. et al. | 2014
- 87
-
Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusionElias-Miró, M. / Mendes-Braz, M. / Cereijo, R. / Villarroya, F. / Jiménez-Castro, M. n. / Gracia-Sancho, J. / Guixé-Muntet, S. / Massip-Salcedo, M. / Domingo, J. C. / Bermudo, R. et al. | 2014
- 96
-
Hirmi Valley liver disease: A disease associated with exposure to pyrrolizidine alkaloids and DDTRobinson, O. / Want, E. / Coen, M. / Kennedy, R. / van den Bosch, C. / Gebrehawaria, Y. / Kudo, H. / Sadiq, F. / Goldin, R. D. / Hauser, M. L. et al. | 2014
- 103
-
Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growthLing, C. C. / Ng, K. T. / Shao, Y. / Geng, W. / Xiao, J. W. / Liu, H. / Li, C. X. / Liu, X. B. / Ma, Y. Y. / Yeung, W. H. et al. | 2014
- 110
-
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary teamDyson, J. / Jaques, B. / Chattopadyhay, D. / Lochan, R. / Graham, J. / Das, D. / Aslam, T. / Patanwala, I. / Gaggar, S. / Cole, M. et al. | 2014
- 118
-
The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACEHucke, F. / Sieghart, W. / Pinter, M. / Graziadei, I. / Vogel, W. / Müller, C. / Heinzl, H. / Waneck, F. / Trauner, M. / Peck-Radosavljevic, M. et al. | 2014
- 127
-
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinomaZeng, S. S. / Yamashita, T. / Kondo, M. / Nio, K. / Hayashi, T. / Hara, Y. / Nomura, Y. / Yoshida, M. / Oishi, N. et al. | 2014
- 135
-
CD141+ myeloid dendritic cells are enriched in healthy human liverKelly, A. / Fahey, R. / Fletcher, J. M. / Keogh, C. / Carroll, A. G. / Siddachari, R. / Geoghegan, J. / Hegarty, J. E. / Ryan, E. J. / O’Farrelly, C. et al. | 2014
- 143
-
The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injuryGrzelak, C. A. / Martelotto, L. G. / Sigglekow, N. D. / Patkunanathan, B. / Ajami, K. / Calabro, S. R. / Dwyer, B. J. / Tirnitz-Parker, J. E. / Watkins, D. N. / Warner, F. J. et al. | 2014
- 152
-
AMPKα1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expressionMerlen, G. g. / Gentric, G. r. / Celton-Morizur, S. v. / Foretz, M. / Guidotti, J. E. / Fauveau, V. r. / Leclerc, J. / Viollet, B. / Desdouets, C. et al. | 2014
- 160
-
Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated miceWeerachayaphorn, J. / Luo, Y. / Mennone, A. / Soroka, C. J. / Harry, K. / Boyer, J. L. et al. | 2014
- 167
-
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver diseaseCusi, K. / Chang, Z. / Harrison, S. / Lomonaco, R. / Bril, F. / Orsak, B. / Ortiz-Lopez, C. / Hecht, J. / Feldstein, A. E. / Webb, A. et al. | 2014
- 175
-
A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitisVenken, K. / Seeuws, S. / Zabeau, L. / Jacques, P. / Decruy, T. / Coudenys, J. / Verheugen, E. / Windels, F. / Catteeuw, D. / Drennan, M. et al. | 2014
- 183
-
Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failureMutanen, A. / Heikkilä, P. i. / Lohi, J. / Raivio, T. / Jalanko, H. / Pakarinen, M. P. et al. | 2014
- 191
-
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?van der Meer, A. J. / Wedemeyer, H. / Feld, J. J. / Hansen, B. E. / Manns, M. P. / Zeuzem, S. / Janssen, H. L. et al. | 2014
- 197
-
Pathological bacterial translocation in liver cirrhosisWiest, R. / Lawson, M. / Geuking, M. et al. | 2014
- 210
-
Autoimmune liver disease, autoimmunity and liver transplantationCarbone, M. / Neuberger, J. M. et al. | 2014
- 224
-
Genetics of hepatocellular carcinoma: The next generationNault, J. C. / Zucman-Rossi, J. et al. | 2014
- 227
-
Antisense therapy for hepatitis C virus infectionde Jong, Y. P. / Jacobson, I. M. et al. | 2014
- 229
-
Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinomaFelga, G. / Salvalaggio, P. R. / de Rezende, M. B. / de Almeida, M. D. et al. | 2014
- 230
-
Reply to: “Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma”Sposito, C. / Mazzaferro, V. et al. | 2014
- 231
-
Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infectionsClaassen, M. A. / Janssen, H. L. / de Knegt, R. J. / Boonstra, A. et al. | 2014
- 232
-
Reply to: “Controversy on the role of FoxP3+ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections”Langhans, B. / Spengler, U. et al. | 2014
- 234
-
From the CUPIC study: Great times are not coming (?)Carvalho-Filho, R. J. / Narciso-Schiavon, J. n. / Schiavon, L. L. et al. | 2014
- 235
-
Reply to: From the CUPIC study: Great times are not coming (?)Carrat, F. / Barthe, Y. / Hezode, C. / Fontaine, H. / Bronowicki, J. P. et al. | 2014
- 237
-
Corrigendum to: “Challenges in cancer vaccine development for hepatocellular carcinoma” [J Hepatol 2013;59:897–903]Buonaguro, L. / Petrizzo, A. / Tagliamonte, M. / Tornesello, M. L. / Buonaguro, F. M. et al. | 2014
- 238
-
Corrigendum to: “Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C” [J Hepatol 2013;59:696–700]Squadrito, G. / Cacciola, I. / Alibrandi, A. / Pollicino, T. / Raimondo, G. et al. | 2014
- I
-
Guide for Authors| 2014
- S1
-
O2 OBETICHOLIC ACID, A FARNESOID-X RECEPTOR AGONIST, REDUCES BACTERIAL TRANSLOCATION AND RESTORES INTESTINAL PERMEABILITY IN A RAT MODEL OF CHOLESTATIC LIVER DISEASEVerbeke, L. / Farre, R. / Covens, K. / Verbinnen, B. / Vanuytsel, T. / Vander Elst, I. / Windmolders, P. / Verhaegen, J. / Komuta, M. / Roskams, T. et al. | 2014
- S2
-
O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDYWedemeyer, H. / Yurdaydin, C. / Ernst, S. / Caruntu, F. A. / Curescu, M. G. / Yalcin, K. / Akarca, U. S. / Gürel, S. / Zeuzem, S. / Erhardt, A. et al. | 2014
- S3
-
O6 SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION IS SAFE AND EFFECTIVE IN DIFFICULT-TO-TREAT POPULATIONS INCLUDING GENOTYPE-3 PATIENTS, DECOMPENSATED GENOTYPE-1 PATIENTS, AND GENOTYPE-1 PATIENTS WITH PRIOR SOFOSBUVIR TREATMENT EXPERIENCEGane, E. J. / Hyland, R. H. / An, D. / Pang, P. S. / Symonds, W. T. / Mchutchison, J. G. / Stedman, C. A. et al. | 2014
- S4
-
O8 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR-CONTAINING REGIMENS FOR HCV GENOTYPE 2 OR 3 INFECTED PATIENTS WHO FAILED PRIOR SOFOSBUVIR PLUS RIBAVIRIN THERAPYEsteban, R. / Nyberg, L. / Lalezari, J. / Ni, L. / Doehle, B. / Kanwar, B. / Brainard, D. / Subramanian, M. / Symonds, W. T. / McHutchison, J. G. et al. | 2014
- S5
-
O11 RETREATMENT OF RELAPSERS TO SOFOSBUVIR/RIBAVIRIN WITH SOFOSBUVIR/LEDIPASVIR: COMPLETE AND RAPID VIROLOGIC SUPPRESSION BY WEEK 4Osinusi, A. / Marti, M. / Townsend, K. / Nelson, A. / Kohli, A. / Silk, R. / Pang, P. / Symonds, W. T. / McHutchison, J. / Masur, H. et al. | 2014
- S6
-
O13 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION IN EUROPEAN PATIENTS WHO RELAPSED AFTER PREVIOUS INTERFERON-BASED THERAPY: THE PROMISE TRIALForns, X. / Lawitz, E. / Zeuzem, S. / Gane, E. J. / Bronowicki, J. P. / Andreone, P. / Horban, A. / Brown, A. S. / Peeters, M. / Lenz, O. et al. | 2014
- S7
-
O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDYMookerjee, R. / Rosselli, M. / Pieri, G. / Beecher-Jones, T. / Hooshmand-Rad, R. / Chouhan, M. / Mehta, G. / Jalan, R. / Shapiro, D. et al. | 2014
- S9
-
O22 TIPS FOR REFRACTORY ASCITES IN CIRRHOSIS: A SINGLE-CENTRE EXPERIENCE USING 8-MM AND 10-MM DIAMETER EXPANDED-POLYTETRAFLUOROETHYLENE (e-PTFE) COVERED STENTLuca, A. / Miraglia, R. / Maruzzelli, L. / Vizzini, G. / Caruso, S. / Tuzzolino, F. et al. | 2014
- S10
-
O24 HEPATOCYTE SPECIFIC KNOCK-OUT OF AUTOPHAGY INDUCES LIVER INJURY, BUT INHIBITS STEATOSIS AND IMPROVES SERUM LIPIDS IN MICE FED A CONTROL AND METHIONINE CHOLINE DEFICIENT DIETKwanten, W. J. / Martinet, W. / De Winter, B. Y. / Van Hoof, V. V. / Bedossa, P. / Michielsen, P. P. / Francque, S. M. et al. | 2014
- S11
-
O27 DOES PNPLA3 INCREASE LIVER FAT BY EXTRA-HEPATIC MECHANISMS?Lallukka, S. / Kotronen, A. / Perttilä, J. / Olkkonen, V. M. / Yki-Järvinen, H. et al. | 2014
- S12
-
O29 ALTERED MITOCHONDRIA IN LIVER-SPECIFIC PROHIBITIN-2 NULL MICE INDUCES HEPATIC DAMAGES ASSOCIATED WITH STEATOSIS AND IMPAIRED GLUCONEOGENESISMartin-Levilain, J. / Supale, S. / Merkwirth, C. / Metzger, D. / Chambon, P. / Langer, T. / Maechler, P. et al. | 2014
- S13
-
O31 GENDER DISPARITY AND REAL-LIFE PRACTICE SETTING DIFFERENCES IN ACTUAL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B MEETING CRITERIA FOR ANTIVIRAL THERAPYKim, L. H. / Nguyen, V. G. / Trinh, H. N. / Li, J. / Zhang, J. Q. / Nguyen, M. et al. | 2014
- S23
-
O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAÏVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDYKowdley, K. V. / Stuart, G. C. / Reddy, R. K. / Rossaro, L. / Bernstein, D. E. / An, D. / Svarovskaia, E. S. / Hyland, R. H. / Pang, P. S. / Symonds, W. T. et al. | 2014
- S24
-
O59 MICE WITH AXIN-1 LIVER SPECIFIC DELETION DEVELOP HEPATOCELLULAR CARCINOMAS WITHOUT BETA-CATENIN ACTIVATIONDahmani, R. / Tournier, E. / Coulouarn, C. / Just, P. A. / Terris, B. / Gilgenkrantz, H. / Perret, C. et al. | 2014
- S25
-
O61 EFFICACY AND SAFETY OF MK-5172 AND MK-8742 ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 INFECTED PATIENTS WITH CIRRHOSIS OR PREVIOUS NULL-RESPONSE: THE C-WORTHY STUDYLawitz, E. / Hezode, C. / Gane, E. / Tam, E. / Lagging, M. / Balart, L. / Rossaro, L. / Ghalib, R. / Shaughnessy, M. / Hwang, P. et al. | 2014
- S26
-
O64 EFFECT OF BASELINE NS5A POLYMORPHISMS ON VIROLOGIC RESPONSE TO THE ALL-ORAL COMBINATION OF DACLATASVIR + SOFOSBUVIR ± RIBAVIRIN IN PATIENTS WITH CHRONIC HCV INFECTIONMcPhee, F. / Zhou, N. / Yang, X. / Hernandez, D. / Chiarella, J. / Kozal, M. et al. | 2014
- S29
-
O71 MASSIVE HEPATIC NECROSIS IS A CRITICAL PATHOLOGICAL FEATURE TO DISTINGUISH ACUTE-ON-CHRONIC LIVER FAILURE AS A SEPARATE ENTITY FROM CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATIONLi, H. / Xia, Q. / Li, S. T. / Yang, S. Y. / Zeng, B. / Wang, T. L. / Weng, H. L. et al. | 2014
- S30
-
O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF)Ariza, X. / Angeli, P. / Barreto, R. / Jalan, R. / Morales Ruiz, M. / Elia, C. / Sola, E. / Garcia, E. / Nevens, F. / Trebicka, J. et al. | 2014
- S31
-
O76 THE OCCURRENCE OF SPONTANEOUS BACTERIAL PERITONITIS CLOSES THE THERAPEUTIC WINDOW OF OPPORTUNITY FOR NON-SELECTIVE BETA BLOCKER TREATMENT IN CIRRHOTIC PATIENTS WITH ASCITESMandorfer, M. / Bota, S. / Schwabl, P. / Bucsics, T. / Pfisterer, N. / Kruzik, M. / Hagmann, M. / Blacky, A. / Ferlitsch, A. / Sieghart, W. et al. | 2014
- S32
-
O79 PROTHROMBOTIC GENETIC RISK FACTORS ARE ASSOCIATED WITH LIVER STIFFNESS IN THE GENERAL POPULATION: RESULTS FROM THE ROTTERDAM STUDYPlompen, E. P. / Darwish Murad, S. / Schouten, J. N. / Hansen, B. E. / Loth, D. W. / Hofman, A. / Uitterlinden, A. G. / Stricker, B. H. / Janssen, H. L. / Leebeek, F. W. et al. | 2014
- S33
-
O82 CLINICAL UTILITY OF NON-INVASIVE MEASURES OF FIBROSIS IN THE AMBULATORY POPULATIONNguyen, T. A. / Deshazo, J. P. / Thacker, L. R. / Sanyal, A. J. et al. | 2014
- S35
-
O86 EUROPEAN RESPONSES IN FOCUS: COMPARING VIRAL HEPATITIS AND HIV RELATED DEATHS IN EUROPE 1990–2010 IN THE GLOBAL BURDEN OF DISEASE STUDY 2010Cowie, B. C. / Allard, N. / MacLachlan, J. H. et al. | 2014
- S36
-
O89 IMPACT OF NEW DAA-CONTAINING REGIMENS ON HCV TRANSMISSION AMONG INJECTING DRUG USERS (IDUS): A MODEL-BASED ANALYSIS (ANRS 12376)Cousien, A. / Tran, V. C. / Jauffret-Roustide, M. / Deuffic-Burban, S. / Dhersin, J. S. / Yazdanpanah, Y. et al. | 2014
- S38
-
O93 GENE EXPRESSION-BASED PROGNOSTIC SIGNATURE AND GENOMIC CHARACTERIZATION OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMACornella, H. / Alsinet, C. / Sayols, S. / Zhang, Z. / Hao, K. / Cabellos, L. / Quaglia, A. / Villanueva, A. / Hoshida, Y. / Nagorney, D. M. et al. | 2014
- S39
-
O96 HEMATOPOIETIC CELLS-DERIVED JNK1 DRIVES HEPATIC INJURY AND HEPATOCELLULAR CARCINOMA IN IKKg/NEMO-DELETED LIVERSCubero, F. J. / Zhao, G. / Nevzorova, Y. A. / Al Masaoudi, M. / Verdier, J. / Peng, J. / Schaefer, F. M. / Hatting, M. / Hermanns, N. / Boekschoten, M. V. et al. | 2014
- S40
-
O99 INFLAMMATORY Wnt DRIVES INTRAHEPATIC CHOLANGIOCARCINOMA GROWTH AND CAN BE THERAPEUTICALLY INHIBITED IN VIVO TO REDUCE TUMOUR BURDENBoulter, L. / Guest, R. V. / Kendall, T. / Walker, R. / Wojtacha, D. / Robson, A. J. / Samuel, K. / Wigmore, S. J. / Sansom, O. J. / Forbes, S. J. et al. | 2014
- S41
-
O102 PROLIFERATION OF HBV-INFECTED HUMAN HEPATOCYTES IN HUMANIZED MICE PROMOTES THE OCCURRENCE OF VIRAL INTEGRATIONS WITHIN THE HOST GENOMEAllweiss, L. / Volz, T. / Giersch, K. / Lohse, A. W. / Petersen, J. / Lütgehetmann, M. / Dandri, M. et al. | 2014
- S42
-
O105 MICE WITH HUMAN LIVERS AS A NEW MODEL OF HEPATITIS E VIRUS INFECTION AND PRECLINICAL DRUG EVALUATIONLutgehetmann, M. / Giersch, K. / Allweiss, L. / Lohse, A. W. / Polywka, S. / Pischke, S. / Petersen, J. / Volz, T. / Dandri, M. et al. | 2014
- S43
-
O108 NATURALLY OCCURRING HBV CORE DELETION MUTANTS ENCODE CORE-POLYMERASE FUSION PROTEINS WHICH BIND TO MICRORNAS PERTURBING THE REGULATORY FUNCTION AND ENHANCING HEPATOMA CELL GROWTHYeh, C. T. / Huang, Y. H. / Tseng, Y. H. / Lin, W. R. / Hung, G. / Chen, T. C. / Lee, W. C. et al. | 2014
- S45
-
O110 AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC – IMPLICATIONS FOR SCREENINGJohnson, P. / Berhane, S. / Satomura, S. / Tada, T. / Kumada, T. / Teng, M. / Skowronska, A. / Cox, T. / Palmer, D. / Yeo, W. et al. | 2014
- S49
-
O118 A MUTATION IN THE HEPATITIS E VIRUS POLYMERASE ASSOCIATED WITH RIBAVIRIN TREATMENT FAILURE HAS A REPLICATION ADVANTAGE IN VITRODebing, Y. / Gisa, A. / Suneetha, P. V. / Bremer, B. / Dallmeier, K. H. / Manns, M. / Pischke, S. / Neyts, J. / Wedemeyer, H. et al. | 2014
- S50
-
O121 SCI-B-VAC IS SUPERIOR TO ENGERIX-B FOR PREVENTING HBV VERTICAL TRANSMISSIONSaed, N. / Hakim, M. / Nijim, Y. / Farah, N. / Jamalia, J. / Nuser, T. / Ismael, K. / Ghantous, R. / Amer, J. / Safadi, R. et al. | 2014
- S52
-
O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PDGiannelli, G. / Faivre, S. / Santoro, A. / Kelley, R. K. / Merle, P. / Gane, E. / Douillard, J. Y. / Waldschmidt, D. / Mulcahy, M. / Costentin, C. et al. | 2014
- S55
-
O133 NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVALVesterhus, M. / Holm, A. / Hov, J. R. / Andersen, I. M. / Schrumpf, E. / Paulsen, V. / Bjørnstad, M. / Lundin, K. / Zweers, S. J. / Vatn, M. et al. | 2014
- S56
-
O134 IDENTIFYING APPROACHES TO INTERVENTION IN PRIMARY SCLEROSING CHOLANGITIS (PSC): EFFECTOR FUNCTIONS OF CD28 NEGATIVE T CELLS AND THEIR MODULATION BY VITAMIN DLiaskou, E. / Jeffery, L. E. / Suresh, S. / Trivedi, P. / Reynolds, G. / Bruns, T. / Adams, D. H. / Sansom, D. M. / Hirschfield, G. M. et al. | 2014
- S57
-
O136 A NOVEL, HYBRID RECOMBINANT AAV-piggyBac TRANSPOSON VECTOR PERMITS ROBUST LONG-TERM PHENOTYPE CORRECTION OF THE PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3 MOUSE MODEL IN VIVOSiew, S. M. / Cunningham, S. C. / Alexander, I. E. et al. | 2014
- S67
-
P3 INVALIDATION OF OSTEOPONTIN AGGRAVATES HEPATIC INJURY INDUCED BY ISCHEMIA–REPERFUSION IN MICEPatouraux, S. / Rousseau, D. / Rubio, A. / Lauron, J. / Bonnafous, S. / Lavallard, V. J. / Saint-Paul, M. C. / Bailly-Maitre, B. / Tran, A. / Crenesse, D. et al. | 2014
- S69
-
P10 INTERFERON LAMBDA 4 (IFNL4) POLYMORPHISM PREDICTS RESPONSE TO HEPATITIS C TREATMENT AFTER LIVER TRANSPLANTATIONFernández-Carrillo, C. / González, P. / Crespo, G. / Coto-Llerena, M. / Navasa, M. / Forns, X. / Pérez-del-Pulgar, S. et al. | 2014
- S70
-
P13 HUMAN INTRAHEPATIC CD4CD25FOXP3 REGULATORY T CELLS TREATED BY RAPAMYCIN AND RETINOIC ACID EFFECTIVELY SUPPRESS ALLOGENIC T EFFECTORS OF PERIPHERAL BLOODSharma, R. / Jabri, Y. / Xystrakis, E. / Srinivasan, P. / Prachalias, A. / Huang, X. / Vijay, G. M. / Heaton, N. / Ma, Y. / Jassem, W. et al. | 2014
- S71
-
P16 ‘IN VIVO’ MAGNETIC RESONANCE SPECTROSCOPY WITH HYPERPOLARIZED PYRUVATE EARLY DETECTS LACTATE FORMATION IN ALF RATSChavarria, L. / Romero-Giménez, J. / Monteagudo, E. / Lope-Piedrafita, S. / Genesca, J. / Cordoba, J. et al. | 2014
- S73
-
P22 NUMERICAL SIMULATIONS TO CHARACTERIZE THE HEPATIC MICROCIRCULATION IN HUMAN CIRRHOSISPeeters, G. / Debbaut, C. / Cornillie, P. / Dierick, M. / Monbaliu, D. / Segers, P. et al. | 2014
- S74
-
P24 L-ORNITHINE PHENYLACETATE REDUCES AMMONIA IN PIGS WITH ACUTE LIVER FAILURE THROUGH PHENYLACETYLGLYCINE FORMATION: A NOVEL AMMONIA-LOWERING PATHWAYKristiansen, R. G. / Rose, C. / Fuskevåg, O. M. / Mæhre, H. / Revhaug, A. / Jalan, R. / Ytrebø, L. M. et al. | 2014
- S75
-
P28 EVIDENCE FOR INTRACELLULAR IMMUNOMODULATORY AND ANTIOXIDANT ACTION OF ALBUMIN TO PROVIDE ENDOTHELIAL PROTECTION IN LIVER FAILUREGarcia Martinez, R. / Andreola, F. / Mehta, G. / Poulter, K. / Oria, M. / Chiara, F. / Jalan, R. et al. | 2014
- S80
-
P42 PPARg AGONIST PIOGLITAZONE REDUCES PORTOSYSTEMIC COLLATERAL BLOOD FLOW VIA MODULATION OF ANGIOGENESIS AND INFLAMMATION IN PPVL RATSSchwabl, P. / Payer, B. A. / Grahovac, J. / Boucher, Y. / Klein, S. / Trebicka, J. / Angermayer, B. / Trauner, M. / Peck-Radosavljevic, M. / Reiberger, T. et al. | 2014
- S83
-
P51 DESUMOYLATION OF HYPOXIA INDUCIBLE FACTOR (HIF)-2a BY SENP1 IS INVOLVED IN HPPCn-ENHANCED SORAFENIB RESISTANCE UNDER HYPOXIA IN HEPATOCELLULAR CARCINOMAZhu, B. / Lin, S. S. / Liu, P. F. / Li, Y. F. / Gao, H. Y. / Su, Z. Y. / Sun, H. Y. / Wang, L. S. / Cui, C. P. et al. | 2014
- S84
-
P54 TEMPORAL DYNAMICS AND THERAPEUTIC POTENTIAL OF THE UNFOLDED PROTEIN RESPONSE IN HEPATOCELLULAR CARCINOMAVandewynckel, Y. P. / Laukens, D. / Geerts, A. / Bogaerts, E. / Paridaens, A. / Verhelst, X. / Van Steenkiste, C. / Descamps, B. / Vanhove, C. / Libbrecht, L. et al. | 2014
- S85
-
P57 SIGNIFICANCE OF SERUM miR-10b-3p IN PREDICTING PRESENCE OF MICROVASCULAR INVASION OF HEPATOCELLULAR CARCINOMA (HCC)Yoon, E. L. / Yeon, J. E. / Ko, E. / Je, J. H. / Yoo, Y. J. / Kang, K. / Kang, S. H. / Kim, H. R. / Lee, H. J. / Suh, S. J. et al. | 2014
- S86
-
P60 HUMAN HEPATOCELLULAR CARCINOMA DENDRITIC CELL INTERACTIONS INDUCE A NOVEL SUBSET OF CD8+REGULATORY T-CELLS WHICH MEDIATE IMMUNOSUPPRESSION THROUGH CD39Li, K. K. / Resheq, Y. J. / Curbishley, S. M. / Ward, S. T. / Bruns, T. / Zimmermann, H. W. / Trivedi, P. J. / Weston, C. J. / Adams, D. H. et al. | 2014
- S87
-
P63 SMAD4-DEPENDENT REGULATION OF HEPATOCELLULAR CARCINOMA GROWTH AND PROGRESSIONHernanda, P. Y. / Kan, C. / Das, A. M. / Sideras, K. / Bots, S. J. / Janssen, H. L. / Kodach, L. L. / Metselaar, H. J. / Kwekkeboom, J. / Sprengers, D. et al. | 2014
- S89
-
P70 STEM CELL NICHE AND MACROPHAGES IN HUMAN CHOLANGIOCARCINOMARaggi, C. / Correnti, M. / Invernizzi, P. et al. | 2014
- S90
-
P73 A TRANSFORMING GROWTH FACTOR KINASE I INHIBITOR, LY2157299, MODULATES STEMNESS-RELATED BIOMARKERS IN HCCRani, B. / Di Turi, F. / Lupo, L. / Cao, Y. / Malfettone, A. / Fabregat, I. / Villa, E. / Giannelli, G. et al. | 2014
- S93
-
P82 TGF-β SIGNALING REGULATOR EXPRESSION IN HUMAN HCC: RESULTS FROM MICROARRAY DATA META ANALYSESDediulia, T. / Dropmann, A. / Itzel, T. / Meindl-Beinker, N. / Teufel, A. / Coulouarn, C. / Dooley, S. et al. | 2014
- S94
-
P85 CHOLANGIOCARCINOMA (CCA) EXPRESS CHEMOKINE RECEPTOR CXCR7: IMPORTANT ROLE OF CXCR7 IN MEDIATING CXCL12 INDUCED CCA CELLS CHEMOTAXIS AND SURVIVALGentilini, A. / Roumbouts, K. / Pinzani, M. / Caligiuri, A. / Raggi, C. / Invernizzi, P. / Raschioni, C. / Marra, F. et al. | 2014
- S95
-
P88 USAGE OF ADAPTER-MEDIATED RETARGETING OF ONCOLYTIC ADENOVIRUSES FACILITATES ANTIGEN-SPECIFIC CD8 T CELL RESPONSES AND LEADS TO REDUCED HEPATOTOXICITY IN MICEUreche, C. I. et al. | 2014
- S96
-
P91 EFFECT OF TOLL-LIKE RECEPTOR 7 AND 9 TARGETED THERAPY TO PREVENT THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMAMohamed, F. / Al-Jehani, R. / Minogue, S. / Andreola, F. / Winstanley, A. / Olde Damink, S. / Malagó, M. / Davies, N. / Loung, T. V. / Dhillon, A. et al. | 2014
- S97
-
P94 c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRODi Maira, G. / Rovida, E. / Navari, N. / Cannito, S. / Sbarba, P. D. / Parola, M. / Marra, F. et al. | 2014
- S98
-
P97 NEW INSIGHTS IN HOXA13 AND HOTTIP ROLE AS PROGNOSTIC FACTORS IN HEPATOCELLULAR CARCINOMAQuagliata, L. / Matter, M. / Piscuglio, S. / Tornillo, L. / Heim, M. / Cillo, C. / Terracciano, L. et al. | 2014
- S99
-
P100 Nur77 MEDIATES BILE ACID-INDUCED DEATH AND SURVIVAL IN LIVER AND COLON CELLSHu, Y. / Chau, T. / Liu, H. X. / Wan, Y. J. et al. | 2014
- S100
-
P103 SUCCESSFUL CRYOPRESERVATION OF HUMAN BILIARY TREE STEM/PROGENITOR CELLS (hbTSCS) ISOLATED FROM ADULT LIVER BASED ON GOOD MANUFACTURING PRACTICECardinale, V. / Gentile, R. / Nevi, L. / Fraveto, A. / Carpino, G. / Torrice, A. / Pasqualino, V. / Melandro, F. / Mennini, G. / Nudo, F. et al. | 2014
- S101
-
P106 ADULT HUMAN BILIARY TREE STEM/PROGENITOR CELLS (hbTSCS) ARE EFFICIENTLY REPROGRAMMED TO FUNCTIONAL INSULIN-SECRETING β-PANCREATIC ISLET CELLS BY A NEWLY SYNTHESIZED HUMAN Pdx1 PEPTIDECardinale, V. / Scafetta, G. / Puca, R. / De Canio, M. / Sicilia, F. / Carpino, G. / Casa, D. / Federici, G. / Berloco, P. B. / Gaudio, E. et al. | 2014
- S102
-
P109 CANALS OF HERING ARE REMNANTS OF DISTAL BILE DUCTS AFTER REGENERATION OF HEPATOCYTES: A STUDY OF EARLY CHRONIC LIVER DISEASE IN HUMANSStueck, A. E. / Wanless, I. R. et al. | 2014
- S103
-
P112 LIVER DAMAGE DETERMINES THE GENE EXPRESSION PROFILE OF LIVER PROGENITOR CELLS AND THEIR CONTRIBUTION TO HEPATIC REGENERATIONRodrigo-Torres, D. / Affò, S. / Coll, M. / Morales-Ibanez, O. / Millán, C. / Blaya, D. / Lozano, J. J. / Caballería, J. / Arroyo, V. / Ginès, P. et al. | 2014
- S107
-
P126 INCREASED FREQUENCY OF CD8 T CELL RESPONSES TO T CELL APOPTOSIS-DERIVED ANTIGENS IN CHRONICALLY-HCV INFECTED INDIVIDUALS NON-RESPONDING TO PEG-IFNa/RIBAVIRINMartini, H. / Citro, A. / Martire, C. / Accapezzato, D. / Cavallari, E. N. / Labbadia, G. / DEttorre, G. / Vullo, V. / Barnaba, V. et al. | 2014
- S108
-
P129 HEPATITIS C VIRUS MEK1- AND TC-PTP-DEPENDENTLY CONVERTS EPIDERMAL GROWTH FACTOR (EGF) INTO A POTENT INDUCTOR OF CXCR2 LIGAND EXPRESSIONGröpper, C. / Triller, N. / Eisenbürger, S. / Bartenschlager, R. / Häussinger, D. / Bode, J. G. et al. | 2014
- S110
-
P135 DEPLETION OF H2O2 BY CATALASE INDUCES MYELOID-DERIVED SUPPRESSOR CELLS – A NOVEL MECHANISM OF IMMUNE-REGULATION BY HEPATIC STELLATE CELLSResheq, Y. J. / Li, K. K. / Wards, S. / Wilhelm, A. / Garg, A. / Curbishley, S. M. / Zimmermann, H. W. / Jitschin, R. / Mougiakakos, D. / Weston, C. et al. | 2014
- S111
-
P138 SERONEGATIVE ACUTE LIVER FAILURE REPRESENTS A MACROPHAGE–T CELL ACTIVATION SYNDROMETriantafyllou, E. / Pop, O. T. / Abeles, R. D. / Khamri, W. / Possamai, L. / Hussain, M. / Bernal, W. / Auzinger, G. / Heneghan, M. A. / Heaton, N. et al. | 2014
- S112
-
P140 MODELLING THE LIVER IMMUNE MICROENVIRONMENT: FACTORS THAT DEFINE ANTIVIRAL ACTIVITY OF T CELLSLawrence, T. M. / Peng, Y. C. / Wilson, G. K. / Zhang, Y. / Thimme, R. / Dong, T. / McKeating, J. A. et al. | 2014
- S113
-
P144 TREM1-DEFICIENCY ACCELERATES VIRAL CLEARANCE IN A MOUSE MODEL OF LCMV-INDUCED ACUTE VIRAL HEPATITISKozik, J. H. / Trautmann, T. / Carambia, A. / Eissing, L. / Lohse, A. W. / Wiegard, C. / Heeren, J. / Herkel, J. et al. | 2014
- S114
-
P147 CD4+ T CELL EGRESS THROUGH HEPATIC EPITHELIA HAS PROFOUND IMPLICATIONS FOR PHENOTYPE AND FUNCTIONNiesen, D. / Liaskou, E. / Jeffery, L. / Purswani, S. / Bruns, T. / Adams, D. H. / McKeating, J. A. / Thimme, R. / Starnataki, Z. et al. | 2014
- S118
-
P159 CO-INHIBITORY RECEPTOR LAG-3 POSITIVE CD8 T CELLS PRODUCE IMMUNOSUPPRESSIVE TGF-β IN CHRONIC HBVLubowiecki, M. / Pallmer, K. / Jajbhay, D. / Pallett, L. J. / Gill, U. / Kennedy, P. T. / Maini, M. / Schurich, A. et al. | 2014
- S119
-
P162 TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL TARGETING OF FVIII EXPRESSION TO OVERCOME IMMUNOLOGICAL RESPONSES TO GENE THERAPY FOR HEMOPHILIA AMerlin, S. / Cannizzo, E. S. / Bruscaggin, V. / Feola, M. / Follenzi, A. et al. | 2014
- S120
-
P164 MONOCYTE EXHAUSTION: A MECHANISTIC EXPLANATION FOR SUSCEPTIBILITY TO INFECTION IN LIVER FAILUREBernsmeier, C. / Patel, V. / Tidswell, R. / Triantafyllou, E. / Singanayagam, A. / Khamri, W. / Agarwal, K. / Heneghan, M. / Willars, C. / Bernal, W. et al. | 2014
- S121
-
P166 A COACH, A PLAYMAKER, A DEFENDER AND STRIKERS: AN EPIGENETIC-TARGET INTERPLAY IN HCV/HCCFouad, M. M. / Elemam, N. M. / Sherif, H. B. / El Sobky, S. A. / Yacoub, R. A. / Abelhamid, A. K. / Elbaz, T. / Mohey El Din, M. A. / Fawzy, I. O. / El Tayebi, H. M. et al. | 2014
- S122
-
P169 INTERFERON INDUCIBLE SECRETED FACTORS RESTRICT HBV BINDINGXia, Y. / Blossey, C. / Esser, K. / Lucifora, J. / Protzer, U. et al. | 2014
- S123
-
P172 COMPARISON OF DIFFERENT IMMUNOREGULATORY PATHWAYS IN HEPATITIS B VIRUS-SPECIFIC CD8+ T-CELL FAILUREBusch, K. / Hoh, A. / Thimme, R. et al. | 2014
- S127
-
P185 PROTEIN KINASE C-INDUCED ENDOCYTOSIS OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE MEDIATES CELLULAR ENTRY OF HEPATITIS B VIRUS IN AN IN VITRO HBV MODELChung, J. W. / Moon, I. Y. / Yang, S. W. / Jang, E. S. / Jeong, S. H. / Kim, J. W. et al. | 2014
- S128
-
P188 A HIGH-THROUGHPUT HDV INFECTION MODEL SYSTEM FOR SCREENING OF ANTIVIRALS AND HOST-TARGETING COMPOUNDSVerrier, E. R. / Tawar, R. G. / Schuster, C. / Brino, L. / Bach, C. / Heydmann, L. / Habersetzer, F. / Doffoel, M. / Mckeating, J. / Sureau, C. et al. | 2014
- S129
-
P191 HEPATITIS B AND C VIRUS PROMOTE CROSSTALK BETWEEN HYPOXIA AND GLUCOCORTICOID SIGNALLING PATHWAYS TO RE-PROGRAMME HEPATOCYTE METABOLISM AND TO EVADE HOST INTERFERONSWilson, G. K. / Meredith, L. W. / Greenland, D. / Mailly, L. / Tennant, D. / Ashcroft, M. / Baumert, T. F. / Tomlinson, J. W. / Hubscher, S. G. / Eeden, F. V. et al. | 2014
- S130
-
P194 THE RISK OF HEPATITIS B-RELATED HEPATOCELLULAR CARCINOMA (HCC) IS REDUCED WITH ANTIVIRAL THERAPY: EVIDENCE FROM 3 HCC PREDICTION MODELSAbu-Amara, M. / Cerecchi, O. / Mahli, G. / Sharma, S. / Yim, C. / Shah, H. / Wong, D. K. / Janssen, H. L. / Feld, J. J. et al. | 2014
- S133
-
P203 THE NEWLY AVAILABLE SEQUENCE-BASED GENOTYPING ASSAYS ARE MORE ACCURATE FOR HEPATITIS C VIRUS (HCV) GENOTYPING THAN PREVIOUS LINE-PROBE ASSAYSMacartney, M. J. / Abdi-Ashir, I. / McCormick, A. L. / Labbett, W. / Irish, D. / Webster, D. P. / Haque, T. et al. | 2014
- S134
-
P206 HEPATITIS C VIRUS COMPARTMENTALISATION: UNRAVELLING GENETIC COMPLEXITY WITHIN THE LIVERHedegaard, D. L. / Tully, D. C. / Reynolds, G. M. / Rowe, I. / Hübscher, S. G. / Power, K. / Tarr, A. W. / Ball, J. / Allen, T. / McKeating, J. A. et al. | 2014
- S135
-
P209 INCREASED DNA METHYLATION IS OBSERVED IN HCV rs12979860 CC HCV PATIENTS WITH LOW HEPATOCELLULAR MxA PROTEIN LEVELSMessineo, A. / DeBoer, B. / Platten, M. / Huang, Y. / Jeffrey, G. / MacQuillan, G. et al. | 2014
- S139
-
P221 VIROLOGY ANALYSES OF SIMEPREVIR IN PHASE 2B AND 3 STUDIESLenz, O. / Verbinnen, T. / Fevery, B. / Tambuyzer, L. / Vijgen, L. / Peeters, M. / Buelens, A. / Beumont-Mauviel, M. / Picchio, G. / de Meyer, S. et al. | 2014
- S140
-
P224 DIFFERENT PROFILE OF NATURAL RESISTANCE TO NS3 PROTEASE INHIBITORS IN HEPATITIS C SUBTYPES 1A AND 1CBagaglio, S. / Messina, E. / Smacchia, A. / Torre, L. D. / Galli, A. / Merli, M. / Hasson, H. / Lazzarin, A. / Uberti-Foppa, C. / Morsica, G. et al. | 2014
- S142
-
P231 HEPATITIS C VIRUS POTENTLY ACTIVATES HUMAN CD161/MAIT (MUCOSAL ASSOCIATED INVARIANT T) CELLSThompson, F. M. / van Wilgenburg, B. / Ramamurthy, N. / Willberg, C. / Oo, Y. H. / Fabris, P. / Klenerman, P. et al. | 2014
- S143
-
P234 MYELOID-DERIVED SUPPRESSOR CELLS AND DENDRITIC CELLS FOR IMPAIRED RESPONSE TO VACCINE IN MICE WITH NONALCOHOLIC FATTY LIVER DISEASEAkbar, S. M. / Chen, S. / Al-Mahtab, M. / Miyake, T. / Hiasa, Y. et al. | 2014
- S144
-
P237 HEPATIC INFLAMMATION INCREASES IN CD36 DEFICIENT MICE FED WITH A HIGH-FAT DIETSheedfar, F. / Oosterveer, M. / Moesker, B. / Kloosterhuis, N. / Runow, K. / de Bruin, A. / Hofker, M. / Koonen, D. et al. | 2014
- S145
-
P240 BILBERRY EXTRACT ATTENUATES DEVELOPMENT OF NONALCOHOLIC STEATOHEPATITIS IN ApoE3L MICEMorrison, M. C. / Liang, W. / Salic, K. / Mulder, P. / Wielinga, P. / Kooistra, T. / Heeringa, P. / Kleemann, R. et al. | 2014
- S147
-
P247 SIMVASTATIN ATTENUATES FIBROSIS IN A NEW RODENT NASH MODEL WITHIN THE METABOLIC SYNDROMESchierwagen, R. / Maybüchen, L. / Klein, S. / Hiththejeti, K. / Lütjohann, D. / Plat, J. / Strassburg, C. P. / Nickenig, G. / Sauerbruch, T. / Zimmer, S. et al. | 2014
- S148
-
P250 BENEFICIAL EFFECTS ON WEIGHT GAIN, HEPATIC STEATOSIS AND EXPRESSION OF LIPOGENIC TARGET GENES IN A MURINE OBESITY MODEL AFTER IL-1 TYPE CYTOKINE INACTIVATIONWohlfahrt, J. / Fettelschoss, A. / Kündig, T. / Hermanns, H. / Müllhaupt, B. / Schmitt, J. / Geier, A. et al. | 2014
- S149
-
P253 ENDOPLASMIC RETICULUM STRESS DOES NOT CONTRIBUTE TO NASH PATHOGENESIS IN OBESE, DIABETIC MICE WITH METABOLIC SYNDROMELegry, V. / Van Rooyen, D. M. / Lambert, B. A. / Sempoux, C. / Poekes, L. / Español-Suñer, R. / Horsmans, Y. / Farrell, G. C. / Leclercq, I. A. et al. | 2014
- S150
-
P257 THE ROLE OF THE ADAPTIVE IMMUNE SYSTEM IN THE DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MORBIDLY OBESE PATIENTSIruzubieta, P. / Loste, M. T. / Puente, A. / Cabezas, J. / Segundo, D. S. / Azueta, A. / Cruz, C. S. / Estebanez, A. / Useros, A. L. / Domínguez, A. et al. | 2014
- S151
-
P260 EFFECTS OF ADENOSINE A2A AND A1 RECEPTORS STIMULATION ON PALMITIC ACID AND HYPOXIA REOXYGENATION INJURY OF STEATOTIC MICE HEPATOCYTESImarisio, C. / Revanna, C. B. / Alchera, E. / Carini, R. et al. | 2014
- S152
-
P263 STEATOSIS-INDEPENDENT PREVENTION OF LIVER FIBROSIS VIA THE TRANSREPRESSIVE ACTIVITY OF PPARaPawlak, M. / Baugé, E. / Bourguet, W. / De Bosscher, K. / Lalloyer, F. / Tailleux, A. / Lebherz, C. / Lefebvre, P. / Staels, B. et al. | 2014
- S153
-
P266 STUDY ON CHANGES OF FFA AND SERUM LIPIDS IN PREECLAMPSIA-LIKE MOUSE MODELS GENERATED BY DIFFERENT MEANSYang, Z. / Han, Y. / Ding, X. et al. | 2014
- S155
-
P273 THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITISPeng, J. / Huang, F. / Li, X. / Chen, L. / Feng, Q. / Hu, Y. et al. | 2014
- S157
-
P276 TLR9 MEDIATES ADIPOSE AND LIVER INFLAMMATION IN METABOLICALLY OBESE MURINE MODELS OF NON-ALCOHOLIC STEATOHEPATITISHaczeyni, F. / Mridha, A. / Yeh, M. / Teoh, N. / Farrell, G. et al. | 2014
- S162
-
P292 ROLE OF NECROPTOSIS IN PATIENTS WITH LIVER DISEASE AND IN RAT LIVER CELL INJURYAfonso, M. B. / Ferreira, D. M. / Cortez-Pinto, H. / Castro, R. E. / Rodrigues, C. M. et al. | 2014
- S163
-
P295 EXPRESSION OF FATTY ACID BINDING PROTEINS (FABPS) IN A MOUSE MODEL OF OBESITY-DEPENDENT HEPATOCELLULAR CARCINOMA (HCC)Thompson, K. J. / Nazari, S. S. / Sindram, D. / McKillop, I. H. et al. | 2014
- S164
-
P298 ACETAMINOPHEN (APAP) FORMULATIONS CONTAINING METHYL-SULFONYL-METHANE AND ISOSILYBIN B AMELIORATE APAP-MEDIATED LIVER TOXICITY WHILE RETAINING APAP EFFICACYYaacov, A. B. / Lichtenstein, Y. / Shabat, Y. / Sobol, T. / Mograbi, Y. / Ilan, Y. et al. | 2014
- S165
-
P300 ALCOHOLIC LIVER DISEASE IN DENMARK 2006–2011: A POPULATION-BASED DESCRIPTIVE STUDYDeleuran, T. / Vilstrup, H. / Becker, U. / Jepsen, P. et al. | 2014
- S166
-
P303 ALCOHOL DRINKING FREQUENCY AND RISK OF ALCOHOLIC CIRRHOSIS IN MIDDLE-AGED WOMEN AND MEN: RESULTS FROM A POPULATION-BASED COHORT STUDYAskgaard, G. / Tolstrup, J. S. et al. | 2014
- S170
-
P313 AMIODARONE HEPATOTOXICITY IS MEDIATED VIA INDUCTION OF STEATOSIS, ER STRESS AND mTOR ACTIVATION IN-VIVO AND IN-VITROErez, N. / Cohen, R. / Uzi, D. / Scaiewicz, V. / Meuller, T. / Tirosh, B. / Shibolet, O. et al. | 2014
- S173
-
P322 ALCOHOLIC LIVER DISEASE ALTERS GLYCOSYLATION-ASSOCIATED GENE EXPRESSIONLee, A. / dAvigdor, W. M. / Christiansen, M. N. / Harrison, M. J. / Packer, N. H. / McLennan, S. V. / Shackel, N. A. et al. | 2014
- S174
-
P325 BACLOFENE LEADS TO ALCOHOL CONSUMPTION REDUCTION AND HEPATIC IMPROVEMENT IN CIRRHOTIC PATIENTSBarrault, C. / Lison, H. / Roudot-Thoraval, F. / Sarlon, E. / Béhar, V. / Medmoun, M. / Rosa Hezode, I. / Belloula, D. / Garioud, A. / Hagege, H. et al. | 2014
- S175
-
P328 ROLE OF MYCOPHENOLATE MOFETIL (MMF) IN STEROID NON RESPONSIVE SEVERE ACUTE ALCOHOLIC HEPATITIS: A RANDOMIZED OPEN LABEL PLACEBO CONTROL PROSPECTIVE CLINICAL PILOT TRIAL – MASH TRIALBasu, P. P. / Aloysius, M. / Shah, N. J. / Brown, R. S. et al. | 2014
- S176
-
P331 HUMAN HEPATIC HepaRG CELLS MAINTAIN HIGH INTRINSIC CYP450 ACTIVITY/METABOLISM AND SIGNIFICANTLY OUTPERFORM STANDARD HepG2/C3A CELLS USED IN DRUG PHARMACOLOGY APPLICATIONSNelson, L. J. / Treskes, P. / Henderson, C. J. / Homer, N. / Morgan, K. / LeBled, C. / Grant, M. H. / Plevris, J. N. et al. | 2014
- S177
-
P333 HUMAN HEPATIC HepaRG CO-CULTURE MODEL AS A SENSITIVE AND NON-INVASIVE TOXICOLOGICAL PLATFORM USING ECIS (ELECTRICAL CELL-SUBSTRATE IMPEDANCE SENSING) BIOSENSORSGamal, W. / Treskes, P. / Chesne, C. / Plevris, J. N. / Bagnaninchi, P. O. / Nelson, L. J. et al. | 2014
- S178
-
P335 DYSFUNCTIONAL GUT MICROBIOTA IN ILEO-COLONIC MUCOSA AND STOOL IN ALCOHOLIC CIRRHOSIS IS ASSOCIATED WITH ENDOTOXEMIA: IMPLICATIONS FOR BACTERIAL TRANSLOCATIONBajaj, J. S. / Heuman, D. / Hylemon, P. / Sikaroodi, M. / Ridlon, J. / Pandak, W. M. / Schubert, M. / Fuchs, M. / White, M. / Daita, K. et al. | 2014
- S180
-
P341 NON-INVASIVE IMAGING OF KUPFFER CELL STATUS USING RADIOLABELLED MANNOSYLATED ALBUMINMahajan, V. / Hartimath, S. / Comley, R. / Stefan-Gueldner, M. / Roth, A. / Poelstra, K. / Reker-Smit, C. / Kamps, J. / Dierckx, R. / de Vries, E. et al. | 2014
- S181
-
P344 TRANSLATIONAL STUDY IDENTIFIES NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A POTENTIAL MEDIATOR OF LIVER INJURY AND FIBROGENESIS IN ALCOHOLIC HEPATITISOdena, G. / Morales-Ibanez, O. / Affo, S. / Furuya, S. / Rusyn, I. / Altamirano, J. / Sancho-Bru, P. / Arroyo, V. / Gines, P. / Caballeria, J. et al. | 2014
- S182
-
P347 INCIDENCE AND RISK FACTORS FOR EXTRA-HEPATIC MALIGNANCIES (EM) IN PRIMARY BILIARY CIRRHOSIS: A COMPARATIVE STUDY FROM TWO EUROPEAN REFERRAL CENTERSCazzagon, N. / Parès, A. / Spinazzè, A. / Caballeria, L. / Reig, A. / Franceschet, I. / Baldo, V. / Buja, A. / Furlan, P. / Floreani, A. et al. | 2014
- S183
-
P350 PREGNANCY AND PRIMARY BILIARY CIRRHOSIS: A CASE–CONTROL STUDYFranceschet, I. / Infantolino, C. / Magne Tene, I. / Cazzagon, N. / Buja, A. / Gervasi, M. T. / Baldo, V. / Floreani, A. et al. | 2014
- S185
-
P355 GENE EXPRESSION ANALYSIS IDENTIFIES IMMUNE SIGNALING AND COMPLEMENT PATHWAYS IN IgG4-RELATED DISEASECulver, E. L. / Marchi, E. / Manganis, C. / Smit, W. / Makuch, M. / Ramamurthy, N. / Rispens, T. / Klenerman, P. / Barnes, E. et al. | 2014
- S186
-
P358 EFFECT OF TAUROURSODEOXYCHOLIC ACID ON ER STRESS IN CHOLESTATIC LIVER DISEASEParidaens, A. / Bogaerts, E. / Vandewynckel, Y. P. / Van Vlierberghe, H. / Geerts, A. / Colle, I. et al. | 2014
- S187
-
P362 THE BILE ACID RECEPTOR TGR5 CONTROLS BILE ACID POOL HYDROPHOBICITY THROUGH REGULATION OF GALLBLADDER MOTOR FUNCTIONPéan, N. / Doignon, I. / Boisgard, R. / Garcin, I. / Julien, B. / Humbert, L. / Schoonjans, K. / Rainteau, D. / Tordjmann, T. et al. | 2014
- S188
-
P364 CHARACTERIZATION AND OUTCOME OF ANTIMITOCHONDRIAL TYPE 2-POSITIVE PATIENTS WITHOUT A DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS: A FRENCH NATIONWIDE PROSPECTIVE STUDYDahlqvist, G. / Gaouar, F. / Carrat, F. / Chazouillères, O. / Poupon, R. / Johanet, C. / Corpechot, C. et al. | 2014
- S189
-
P367 PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAD AN INADEQUATE RESPONSE TO URSODEOXYCHOLIC ACIDHirschfield, G. M. / Gershwin, M. E. / Strauss, R. / Mayo, M. J. / Levy, C. / Zou, B. / Selmi, C. / Marschall, H. U. / Lindor, K. et al. | 2014
- S192
-
P374 LONG-TERM TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH THE FXR AGONIST OBETICHOLIC ACID SHOWS DURABLE EFFICACYKowdley, K. / Hirschfield, G. / Chapman, R. / Vincent, C. / Jones, D. / Pares, A. / Luketic, V. / Gordon, S. / Pencek, R. / Marmon, T. et al. | 2014
- S193
-
P377 THE FXR AGONIST OBETICHOLIC ACID IMPROVES A TRANSPLANT-FREE SURVIVAL-PROVEN BIOCHEMICAL RESPONSE CRITERION IN PLACEBO CONTROLLED PRIMARY BILIARY CIRRHOSIS STUDIESLuketic, V. / Gordon, S. G. / Vincent, C. / Chapman, R. / Mayo, M. / Kowdley, K. / Hirschfield, G. / Mason, A. / Lindor, K. / Macconell, L. et al. | 2014
- S194
-
P380 EXPRESSION OF THE FIBROBLAST GROWTH FACTOR 19 (FGF19) IN THE LIVER CORRELATES WITH CLINICAL AND LABORATORY MEASURES IN PATIENTS WITH PRIMARY BILIARY CIRRHOSISWunsch, E. / Milkiewicz, M. / Kempińska-Podhorodecka, A. / Raszeja-Wyszomirska, J. / Trottier, J. / Barbier, O. / Milkiewicz, P. et al. | 2014
- S196
-
P386 Th17 EFFECTOR CELLS MAY BE INVOLVED IN THE BILE DUCT DAMAGE CHARACTERISTIC OF AUTOIMMUNE SCLEROSING CHOLANGITISLiberal, R. / Grant, C. R. / Ma, Y. / Heneghan, M. A. / Mieli-Vergani, G. / Vergani, D. / Longhi, M. S. et al. | 2014
- S197
-
P389 PROTECTIVE ROLE OF MEMBRANE BILE ACID RECEPTOR TGR5 (GPBAR1) IN DDC-INDUCED SCLEROSING CHOLANGITIS IN MICEBaghdasaryan, A. / Jha, P. / Müller, M. / Agostinelli, L. / Saccomanno, S. / Auer, N. / Deutschmann, A. / Zöhrer, C. / Auwerx, J. / Marzioni, M. et al. | 2014
- S198
-
P391 CD2-SPECIFIC OVEREXPRESSION OF CREM ALPHA AGGRAVATES ACUTE CONCANAVALIN A-INDUCED HEPATITISHammerich, L. / Schönherr, C. / Stefkova, M. / Ohl, K. / Luedde, T. / Trautwein, C. / Tenbrock, K. / Tacke, F. et al. | 2014
- S200
-
P398 AUTOIMMUNE HEPATITIS IS A TH1-DRIVEN DISEASEBovensiepen, C. / Sebode, M. / Lohse, A. W. / Schramm, C. / Herkel, J. / Weiler-Normann, C. et al. | 2014
- S201
-
P401 DISEASE PROGRESSION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS UNDER LONG-TERM TREATMENT WITH URSODEOXYCHOLIC ACID – A HISTOLOGY-BASED ANALYSISSinakos, E. / Vasiliadis, T. / Goulis, I. / Papalavrentios, L. / Perlepe, N. / Patsiaoura, K. / Hytiroglou, P. / Akriviadis, E. et al. | 2014
- S202
-
P404 IDENTIFICATION OF NEW BIOMARKERS IN HEPATITIS B RELATED HEPATOCELLULAR CARCINOMA PATIENTS USING THE MASS SPECTROMETRY AND WESTERN BLOT ANALYSISLee, J. H. / Shim, J. H. / Song, G. W. / Jun, M. J. / Lim, Y. S. / Choi, S. W. / Suh, D. J. et al. | 2014
- S203
-
P407 HBeAg INDEX AND HBVDNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UPPhisalprapa, P. / Charatcharoenwitthaya, P. / Chainuwatti, S. / Chotiyaputta, W. / Nimanong, S. / Tanwandee, T. et al. | 2014
- S205
-
P413 ROLE OF KINASES EGFR AND SRC IN ESTRADIOL 17β-GLUCURONIDE (E17G) INDUCED CHOLESTASIS IN ISOLATED RAT HEPATOCYTES COUPLETS (IRHC)Barosso, I. R. / Zucchetti, A. E. / Miszczuk, G. S. / Roma, M. G. / Crocenzi, F. A. / Sánchez Pozzi, E. J. et al. | 2014
- S206
-
P415 PREVENTION OF CHEMOTHERAPY-INDUCED HBV-RELATED HEPATITIS FLARE IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION: COST ANALYSISTsou, H. H. / Yang, H. C. / Chuang, M. H. / Wu, H. Y. / Hsu, Y. T. / Chang, W. J. / Hsiao, C. F. / Hsu, C. et al. | 2014
- S207
-
P419 HGF SIGNALING PATHWAY AND CELL POLYPLOIDIZATION IN CHOLESTATIC LIVERKiparoidze, S. / Dzidziguri, D. / Bakuradze, E. / Modebadze, I. / Nebieridze, G. et al. | 2014
- S208
-
P422 SERUM HYALURONIC ACID AS A NON-INVASIVE TOOL TO DIAGNOSE SCHISTOSOMAL PERIPORTAL FIBROSIS IN SCHISTOSOMA MANSONI ENDEMIC AREAS OF ETHIOPIAHaile, F. M. / Berhe, N. et al. | 2014
- S211
-
P431 BRAF AND FHIT EXPRESSION IN HCV RELATED CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AND THEIR ASSOCIATION WITH PROGNOSTIC ANATOMOPATHOLOGICAL FEATURESVidigal, P. V. / Garcia, P. P. / Osório, F. M. / Couto, C. A. / do Carmo, P. A. / de Marco, L. A. et al. | 2014
- S213
-
P438 PEFORMANCE OF LIVER ULTRASOUND IN DIAGNOSING AND ASSESSING THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE: A PROSPECTIVE STUDYAlquiroz, R. P. / Cua, I. H. / Bocobo, J. / Cervantes, J. et al. | 2014
- S215
-
P441 PREDICTION OF PORTAL HYPERTENSION AND ESOPHAGEAL VARICES IN CIRRHOTIC PATIENTS WITH APPARENT DIFFUSION COEFFICIENT OF THE SPLEENAbdel Razeka, A. A. / El-Bendary, M. / Motawea, E. / Massoud, S. M. / Abdel-Aziz, M. R. / Zalata, K. et al. | 2014
- S216
-
P444 PREDICTION OF ESOPHAGEAL VARICES USING ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY IN CIRRHOTIC PATIENTS: DEVELOPMENT AND VALIDATION OF A NOVEL PREDICTIVE MODEL (KOREAN MULTI-CENTER STUDY)Park, Y. / Kim, S. U. / Park, S. Y. / Kim, B. K. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Tak, W. Y. / Kweon, Y. O. / Han, K. H. et al. | 2014
- S220
-
P455 BACTERIAL ENDOCARDITIS IN PATIENTS WITH CIRRHOSIS: A MULTICENTER RETROSPECTIVE STUDY OF 78 CASESCadranel, J. F. / Allaire, M. / Blasco-Perrin, H. / Thevenot, T. / Chagneau-Derrode, C. / Pariente, E. A. / Garioud, A. / Lison, H. / Causse, X. / Adhoute, X. et al. | 2014
- S221
-
P458 VALIDATION OF EncephalApp_stroop FOR MINIMAL HEPATIC ENCEPHALOPATHY SCREENING: A MULTI-CENTER US STUDYAllampati, S. / Duarte-Rojo, A. / Thacker, L. / White, M. / Noble, N. / Unser, A. / OShea, R. S. / Flud, C. R. / Klair, J. S. / Bajaj, J. S. et al. | 2014
- S223
-
P464 RESISTANCE TO THROMBOMODULIN IS ASSOCIATED WITH DE NOVO PORTAL VEIN THROMBOSIS AND COULD BE A MODIFIABLE FACTOR TO IMPROVE PROGNOSIS IN PATIENTS WITH CIRRHOSISLa Mura, V. / Tripodi, A. / Cavallaro, F. / Chantarangkul, V. / Colombo, M. / Primignani, M. et al. | 2014
- S224
-
P467 EVALUATION OF CIRRHOTIC CARDIOMYOPATHY IN END STAGE VIRUS C HEPATITIS BY CARDIAC MAGNETIC RESONANCEOmran, D. / Behairy, N. / Mahmoud, M. et al. | 2014
- S225
-
P470 IRON OVERLOAD IN CIRRHOSIS IS ASSOCIATED TO LIVER INSUFFICIENCY AND CIRCULATORY DYSFUNCTION BUT NOT PORTAL HYPERTENSIONRipoll, C. / Keitel, F. / Hollenbach, M. / Zipprich, A. et al. | 2014
- S227
-
P475 ADRENAL INSUFFICIENCY IN CRITICALLY ILL CIRRHOTIC PATIENTS: PREVALENCE, RISK FACTORS AND IMPACT ON MORTALITYNair, H. / Nandish, H. / Shyamsundar, S. / Menon, A. / Mumtaz, K. / Harishkumar, K. / Vallath, B. et al. | 2014
- S228
-
P478 RESOURCE USE ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER DISEASEOrr, J. G. / Morgan, C. L. / Jenkins-Jones, S. / Hudson, M. / Conway, P. / Radwan, A. / Currie, C. J. et al. | 2014
- S229
-
P480 COMPARING SCORING SYSTEMS AS A PREDICTOR OF MORTALITY IN ALCOHOLIC HEPATITISSidhu, S. / Reddick, C. / Mcwhirter, K. / Al-Rifai, A. et al. | 2014
- S230
-
P483 CK 18 BASED SERUM APOPTOTIC CELL DEATH MARKER M30 PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSISWaidmann, O. / Brunner, F. / Herrmann, E. / Zeuzem, S. / Piiper, A. / Kronenberger, B. et al. | 2014
- S231
-
P487 DETERMINANTS OF RATE OF RISE OF SERUM SODIUM IN CRITICALLY ILL CIRRHOTIC PATIENTS WITH LACTULOSE INDUCED HYPERNATREMIA – A RETROSPECTIVE STUDYRamanarayanan, S. / Nayak, S. / Mathur, R. P. / Sarin, S. K. et al. | 2014
- S232
-
P490 URINARY METABOLIC PROFILING BY H NMR SPECTROSCOPY IN PATIENTS WITH CIRRHOSIS DISCRIMINATES OVERT BUT NOT MINIMAL HEPATIC ENCEPHALOPATHYMcPhail, M. J. / Villa, M. / Cox, I. J. / Williams, R. / Amodio, P. / Montagnese, S. / Taylor-Robinson, S. D. et al. | 2014
- S235
-
P499 ALTERED GUT MICROBIOME IS ASSOCIATED WITH NEURO-INFLAMMATION ON BRAIN MRI IN CIRRHOSIS: IMPLICATIONS FOR THE GUT–LIVER–BRAIN AXISBajaj, J. S. / Ahluwalia, V. S. / Sikaroodi, M. / Wade, J. / White, M. / Heuman, D. / Gilles, H. / Unser, A. / Hylemon, P. / Gillevet, P. M. et al. | 2014
- S239
-
P510 GASTROINTESTINAL ISCHEMIA IN PATIENTS WITH ACUTE AND CHRONIC PORTAL VEIN THROMBOSISHarki, J. / Plompen, E. P. / van Noord, D. / Hoekstra, J. / Kuipers, E. J. / Janssen, H. L. / Tjwa, E. T. et al. | 2014
- S240
-
P513 A SIMPLE MODEL FOR THE PREDICTION OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY AND VALIDATION IN AN INDEPENDENT COHORTPasquale, C. / Nardelli, S. / Pentassuglio, I. / Gioia, S. / Onori, E. / Piazza, N. / Amodio, P. / De Rui, M. / Schiff, S. / Farcomeni, A. et al. | 2014
- S241
-
P516 Pro-C5: A NOVEL SEROLOGICAL MARKER OF TRUE TYPE V COLLAGEN FORMATION DETECTS PORTAL HYPERTENSION IN CIRRHOSISLeeming, D. J. / Nielsen, M. J. / Karsdal, M. A. / Veidal, S. S. / Trebicka, J. / Bendtsen, F. / Krag, A. / Møller, S. et al. | 2014
- S242
-
P519 CD133+ HEMATOPOIETIC STEM CELLS REINFUSION IN END-STAGE LIVER DISEASE (ESLD): FINAL RESULTS OF A PHASE I CLINICAL TRIALMargini, C. / Brodosi, L. / Lorenzini, S. / Catani, L. / Giudice, V. / Giordano, R. / Casadei, A. / Sollazzo, D. / Foschi, F. G. / Baccarani, M. et al. | 2014
- S243
-
P521 PROPOSAL FOR A NEW, STEPWISE ALGORITHM COMBINING LIVER AND SPLEEN STIFFNESS AND LOK SCORE FOR DIAGNOSIS OF LARGE ESOPHAGEAL VARICES IN PATIENTS WITH LIVER CIRRHOSISStefanescu, H. / Procopet, B. / Platon Lupsor, M. / Maniu, A. / Radu, C. et al. | 2014
- S244
-
P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-AgMaieron, A. / Hametner, S. / Ferlitsch, M. / Etschmaier, A. / Schoefl, R. / Ziachehabi, A. / Trubert-Exinger, D. / Ferlitsch, A. et al. | 2014
- S245
-
P527 ACUTE CHANGES IN PORTAL PRESSURE GRADIENT (PPG) AFTER PTFE-COVERED TIPS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSIVE COMPLICATIONS: INTRAINDIVIDUAL COMPARISON OF 6-mm AND 8-mm STENT DILATATIONLuca, A. / Miraglia, R. / Maruzzelli, L. / DAmico, M. / Tuzzolino, F. et al. | 2014
- S246
-
P530 FACTORS ASSOCIATED WITH ADIPONECTIN SERUM LEVELS IN PATIENTS WITH LIVER CIRRHOSISSilva, T. E. / Silva, M. C. / Alencar, M. L. / Coelho, M. S. / Wildner, L. M. / Bazzo, M. L. / Chica, D. A. / Dantas-Correa, E. B. / Narciso-Schiavon, J. L. / Schiavon, L. L. et al. | 2014
- S247
-
P534 SPECTRUM AND OUTCOME OF BACTERIAL INFECTIONS AT ADMISSION IN PATIENTS WITH ALCOHOLIC AND NON-ALCOHOLIC CIRRHOSISSahney, A. / Jindal, A. / Vyas, T. / Philip, C. / Vashishtha, C. / Taneja, S. / Khillan, V. / Sarin, S. K. et al. | 2014
- S248
-
P537 eLAAR (THE ENHANCED LIVER ABDOMINAL AREA RATIO): HOW TO USE CROSS-SECTIONAL IMAGING TO ASSESS PROGNOSIS IN END-STAGE CIRRHOSISAlam, S. / Farrell, C. / Fernando, R. / Patanwala, I. / Cross, T. J. et al. | 2014
- S249
-
P540 HEMODYNAMIC CHANGES IN CIRRHOTIC PATIENTS FOLLOWING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) INSERTION: A MATCHED ANALYSISForde, K. A. / McLean, R. C. / Rivera, M. / Tanapanpanit, O. / Soulen, M. / Reddy, K. R. et al. | 2014
- S250
-
P543 INCREASED DNA DAMAGE IN HEPATITIS C VIRUS RELATED HEPATOCELLULAR CARCINOMAShawki, S. / Meshaal, S. / El Dash, A. / Zayed, N. / Hanna, M. et al. | 2014
- S251
-
P547 LOCAL RECURRENCE IN THE TUMOR BLOOD DRAINAGE AREA AFTER RADIOFREQUENCY ABLATIONHirooka, M. / Ochi, H. / Koizumi, Y. / Hiraoka, A. / Tada, F. / Miyake, T. / Tokumoto, Y. / Abe, M. / Hiasa, Y. et al. | 2014
- S254
-
P557 THE RED CELL DISTRIBUTION WIDTH (RDW) IS A NOVEL POWERFUL, INEXPENSIVE PREDICTOR OF SURVIVAL FOR PATIENTS WHO PRESENT WITH HEPATOCELLULAR CARCINOMAGrossi, G. / Smirne, C. / Burlone, M. E. / Pinato, D. J. / Minisini, R. / Pirisi, M. et al. | 2014
- S255
-
P559 CONTINENTAL DIFFERENCES AMONG HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA: EUROPE VS. NORTH AMERICAVentura, M. / Badshah, M. B. / Harris, M. / Merchante, N. / Chen, T. Y. / Qazi, N. / Vispo, E. / Tossonian, H. / Klinker, H. / Marks, K. et al. | 2014
- S256
-
P562 ASSESSMENT OF MALIGNANT POTENTIAL OF HEPATIC HYPOVASCULAR NODULES USING COMBINATION IMAGING STUDIES IN PATIENTS WITH CHRONIC LIVER DISEASETanaka, Y. / Nakazawa, T. / Minamino, T. / Takada, J. / Okuwaki, Y. / Watanabe, M. / Hidaka, H. / Akitaka, S. / Keiji, M. / Wasaburo, K. et al. | 2014
- S257
-
P565 EXPRESSIONS OF EUKARYOTIC TRANSLATION INITIATION FACTOR 3M AND MACROPHAGE MIGRATION INHIBITORY FACTOR IN HAPATOCELLULAR CARCINOMAJeong, J. S. / Han, S. Y. / Ju, M. H. / Paik, Y. H. / Lee, S. W. et al. | 2014
- S258
-
P568 VIROLOGICAL AND CLINICO-PATHOLOGICAL FACTORS IN PREDICTING RECURRENCE OF HEPATITIS B RELATED HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTIONHung, I. F. / Wong, D. K. / Fong, D. Y. / Chui, A. H. / Seto, W. / Fung, J. Y. / Yuen, J. C. / Tiu, R. / Choi, O. / Lai, C. L. et al. | 2014
- S259
-
P571 GADOLINIUM ETHOXYBENZYL DIETHYLENETRIAMINEPENTAACETIC ACID MAGNETIC RESONANCE IMAGING AND CONTRAST ENHANCED ULTRASONOGRAPHY WITH SONAZOID AS PART OF THERAPEUTIC STRATEGIES FOR SMALL NONHYPERVASCULAR HEPATIC NODULAR LESIONSTsuchiya, K. / Yasui, Y. / Takada, H. / Nakakuki, N. / Matsuda, S. / Kaneko, S. / Muraoka, M. / Yamashita, K. / Hattori, N. / Tamaki, N. et al. | 2014
- S260
-
P574 HIGH SENSITIVITY C-REACTIVE PROTEIN IS AN INDEPENDENT PREDICTOR FOR RECURRENCE AND SURVIVAL AFTER CURATIVE TREATMENT AMONG PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA IN EARLY STAGEFujiwara, N. / Tateishi, R. / Nakagomi, R. / Kondo, M. / Minami, T. / Sato, M. / Uchino, K. / Enooku, K. / Nakagawa, H. / Kondo, Y. et al. | 2014
- S262
-
P580 NONINVASIVE BLOOD FIBROSIS INDICES PREDICT INTRAHEPATIC RECURRENCE AFTER CURATIVE RESECTION OF HEPATOCELLULAR CARCINOMAChoi, W. M. / Lee, J. H. / Cho, Y. Y. / Lee, M. / Yoo, J. J. / Cho, Y. / Lee, D. H. / Lee, Y. B. / Yu, S. J. / Kim, Y. J. et al. | 2014
- S263
-
P583 TELOMERE DYSFUNCTION AND TELOMERASE MUTATIONS ARE RISK FACTORS FOR HEPATOCELLULAR CARCINOMATeixeira, A. C. / Scatena, N. F. / Santana-Lemos, B. A. / Gutierrez, F. R. / Barros, A. C. / Secaf, M. / Calado, R. T. / Martinelli, A. L. et al. | 2014
- S266
-
P592 3,3′-DIINDOLYLMETHANE MODULATES THE IMBALANCE OF TREGS TO Th17 CELLS DURING LIVER FIBROGENESIS THROUGH ACTIVATING THE ARYL HYDROCARBON RECEPTOR AND INHIBITING TOLL-LIKE RECEPTOR 4Liu, Y. / Jiang, W. et al. | 2014
- S267
-
P595 THE EXPRESSION AND FUNCTION OF THE TNF SUPERFAMILY LIGAND, TWEAK AND ITS RECEPTOR FN14 IN LIVER FIBROSISWilhelm, A. / Munir, M. / Humphreys, E. H. / Adams, D. H. / Burkly, L. C. / Afford, S. C. / Weston, C. J. et al. | 2014
- S268
-
P598 ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) GENE THERAPY USING A HIGH EFFICIENCY AND LIVER-SPECIFIC ADENO-ASSOCIATED VIRAL VECTOR ATTENUATES EXPERIMENTAL LIVER FIBROSIS IN MICEMak, K. Y. / Chin, R. / Torresi, J. / Cunningham, S. C. / Alexander, I. E. / Angus, P. W. / Herath, C. B. et al. | 2014
- S269
-
P601 CCR6 DEFICIENCY ENHANCES LIVER INFLAMMATION AND FIBROSIS BY MODULATING HEPATIC MACROPHAGES M1/M2 BALANCE AND INFLAMMATORY CELLS RECRUITMENTAffò, S. / Rodrigo-Torres, D. / Blaya, D. / Morales-Ibanez, O. / Millán, C. / Arroyo, V. / Caballería, J. / Ginès, P. / Bataller, R. / Sancho-Bru, P. et al. | 2014
- S273
-
P613 THE EXTRACELLULAR PROTEINASE Expi/Wfdc18 IS INDUCED BY TOLL-LIKE RECEPTOR 9 (TLR9) IN MACROPHAGES AND ENHANCES HEPATIC FIBROGENESISLiebe, R. / Hall, R. / Dooley, S. / Lammert, F. et al. | 2014
- S274
-
P617 MECHANOSENSITIVE SIGNALLING VIA Yap/Taz DURING HEPATIC STELLATE CELL ACTIVATIONPritchett, J. P. / Martin, K. / Llewellyn, J. / Henderson, D. / Athwal, V. / Hanley, N. / Piper Hanley, K. et al. | 2014
- S275
-
P620 THE AMPK-RELATED KINASE, Nuak2 IS MODULATED BY THE ACTIVATION PROCESS AND REGULATES MOTILITY OF HEPATIC STELLATE CELLS (HSC)Tosti-Guerra, C. / Caligiuri, A. / Provenzano, A. / Rombouts, K. / Bertolani, C. / Pinzani, M. / Marra, F. et al. | 2014
- S276
-
P623 NCU-G1GT/GT MICE: A LONG-LIVED MODEL FOR LIVER FIBROSISKong, X. Y. / Nesset, C. K. / Schjalm, C. / Løberg, E. M. / Rustan, A. C. / Thoresen, G. H. / Kase, E. T. / Eskild, W. et al. | 2014
- S277
-
P627 ANALYSIS OF METABOLIC ACTIVITIES IN FETAL AND ADULT HUMAN HEPATOCYTES FOR CLINICAL THERAPYGramignoli, R. / Strom, S. C. et al. | 2014
- S278
-
P630 AUTOPHAGY REGULATES HEPATOCYTES DIFFERENTIATION DURING EPITHELIAL TO MESENCHYMAL (EMT) AND MESENCHYMAL TO EPITHELIAL TRANSITION (MET) BY PROMOTING SNAIL DEGRADATIONGrassi, G. / Di Caprio, G. / Santangelo, L. / Komatsu, M. / Fimia, G. M. / Piacentini, M. / Tripodi, M. / Alonzi, T. et al. | 2014
- S279
-
P633 REGULATION OF LIVER FIBROSIS BY TUNING M2 MACROPHAGE POLARIZATION THROUGH IL-4Rα INHIBITIONWeng, S. Y. / Padberg, K. / Wang, X. Y. / Kim, Y. O. / Crosby, J. / McCaleb, M. / Schuppan, D. et al. | 2014
- S280
-
P636 A SCORING SYSTEM FOR PREDICTING SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS B PATIENTS WITH NORMAL OR MILDLY ELEVATED ALANINE AMINOTRANSFERASE LEVELSWang, H. / Yan, R. / Zhou, Y. / Ru, G. Q. / Wang, M. S. et al. | 2014
- S282
-
P643 HEPATITIS B SURFACE ANTIGEN IN LATE HEPATITIS B INFECTIONZeng, D. W. / Zhu, Y. Y. / Dong, J. / Jiang, J. J. / Liu, Y. R. et al. | 2014
- S283
-
P646 DETECTABLE HEVRNA IN PATIENTS WITH A SEROLOGICAL PROFILE CONSISTENT WITH PREVIOUS INFECTIONHaywood, B. / Tedder, R. S. / Ijaz, S. et al. | 2014
- S284
-
P649 HIGH VIPERIN mRNA EXPRESSION IN THE LIVER IS PREDICTIVE OF HDVRNA LOSS IN HBV/DELTA CO-INFECTED PATIENTSCarey, I. / Hughes, S. A. / Shang, D. / Childs, K. / Bruce, M. / Horner, M. / Fletcher, I. / Joshi, D. / Harrison, P. M. / Agarwal, K. et al. | 2014
- S285
-
P652 CLINICAL CHARACTERISTICS OF HEPATITIS B VIRUS REACTIVATION IN A PROSPECTIVE LONG-TERM STUDY FOR PATIENTS WITH HEMATOLOGIC MALIGNANCYTamori, A. / Hino, M. / Kawamura, E. / Hagihara, A. / Fujii, H. / Uchida-Kobayashi, S. / Iwai, S. / Morikawa, H. / Nakamae, H. / Enomoto, M. et al. | 2014
- S286
-
P655 GENDER DIFFERENCE IN THE EFFECT OF HEPATITIS B VIRUS GENOTYPE ON DISEASE PROGRESSIONJeng, R. W. / Chen, Y. C. / Liaw, Y. F. et al. | 2014
- S287
-
P658 LOW RISK OF HEPATITIS B VIRUS REACTIVATION IN HBsAg NEGATIVE, ANTI-HBc POSITIVE CARRIERS UNDERGOING RITUXIMAB FOR RHEUMATOID ARTHRITISViganò, M. / Varisco, V. / Lampertico, P. / Batticciotto, A. / Mascheroni, A. / Gibertini, P. / Pellerito, R. / Rovera, G. / Caporali, R. / Todoerti, M. et al. | 2014
- S288
-
P661 APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALSKim, W. R. / Berg, T. / Asselah, T. / Flisiak, R. / Fung, S. / Gordon, S. / Janssen, H. L. / Lampertico, P. / Lau, D. / Bornstein, J. D. et al. | 2014
- S290
-
P666 PREDICTORS OF SEVERE HEPATIC FIBROSIS IN TREATMENT-NAIVE GENOTYPE B OR C INFECTED E ANTIGEN-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B PATIENTSSu, W. P. / Peng, C. Y. / Lai, H. C. / Lin, C. H. / Chuang, P. H. / Chen, S. H. et al. | 2014
- S291
-
P669 A GENOME-WIDE ASSOCIATION STUDY ON PERSISTENT HBV INFECTION AND ITS CLINICAL SIGNIFICANCE IN MALE HAN-TAIWANESEChang, S. W. / Fann, C. S. / Su, W. H. / Wang, Y. C. / Weng, C. C. / Yu, C. J. / Hsu, C. L. / Hsieh, A. R. / Chien, R. N. / Chu, C. M. et al. | 2014
- S292
-
P672 HBeAg LEVELS DIFFER ACCORDING TO HBV GENOTYPE IN IMMUNE CLEARANCE DISEASEBayliss, J. / Thompson, A. / Rosenberg, G. / Gaggar, A. / Kitrinos, K. / Gane, E. / Chan, H. L. / Li, X. / Littlejohn, M. / Yuen, L. et al. | 2014
- S293
-
P674 SERUM LEVELS OF HEPATITIS B SURFACE ANTIGEN PREDICT LONG-TERM TRAJECTORIES OF HEPATITIS B VIRAL LOADLiu, J. / Yang, H. I. / Chen, C. F. / Lee, M. H. / Batrla-Utermann, R. / Jen, C. L. / Lu, S. N. / Wang, L. Y. / You, S. L. / Chen, C. J. et al. | 2014
- S294
-
P677 HEPATIC STEATOSIS DOES NOT PREDICT REGRESSION OF LIVER CIRRHOSIS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)Buti, M. / Washington, M. K. / Gane, E. / Aguilar Schall, R. / Bornstein, J. D. / Subramanian, M. / McHutchison, J. G. / Flisiak, R. / Janssen, H. L. / Marcellin, P. et al. | 2014
- S295
-
P680 A NATIONAL HEALTH SYSTEM RESPONSE TO CHRONIC HEPATITIS B: USING POPULATION DATA TO DEFINE GAPS IN CLINICAL CARE PROVISIONAllard, N. / MacLachlan, J. H. / Cowie, B. et al. | 2014
- S296
-
P683 INFLUENCE OF A NTCP RECEPTOR GENE POLYMORPHISM ON HEPATITIS B VIRUS (HBV) INFECTIONDietz, J. / Knop, V. / Vermehren, J. / Füller, C. / Perner, D. / Hüppe, D. / Mauss, S. / Zeuzem, S. / Sarrazin, C. et al. | 2014
- S297
-
P686 EXTRAHEPATIC REPLICATION OF HEPATITIS E VIRUS IN HUMAN PLACENTA: ITS CLINICAL IMPLICATIONSDeka, P. / Das, B. C. / Hazam, R. K. / Kumar, A. / Kar, P. et al. | 2014
- S298
-
P689 DIFFERENTIATION OF PATIENTS WITH HBeAg NEGATIVE HEPATITIS VERSUS HBeAg NEGATIVE INACTIVE CARRIER STATUS BY SERUM CYTOKINES AND CHEMOKINESWiegand, S. B. / Wranke, A. / Falk, C. / Deterding, K. / Manns, M. P. / Wedemeyer, H. / Cornberg, M. et al. | 2014
- S299
-
P692 HIGH NORMAL ALT AND BORDERLINE HBVDNA WERE PREDICTORS FOR FUTURE TREATMENT ELIGIBILITY IN CHRONIC HEPATITIS B (CHB) PATIENTS WHO INITIALLY DID NOT MEET CRITERIAUribe, L. / Nguyen, N. / Nguyen, L. / Kim, L. H. / Trinh, H. N. / Nguyen, M. H. et al. | 2014
- S300
-
P695 APPLICATION OF TAQMAN LOW-DENSITY ARRAYS FOR SIMULTANEOUS RAPID DETECTION OF MULTIPLE PATHOGENS ASSOCIATED WITH JAUNDICEHeaney, J. / Davies, S. E. / Alexander, G. J. / Curran, M. D. et al. | 2014
- S302
-
P701 AUTOCHTHONOUS ACUTE HEPATITIS E IN SWITZERLAND: INCREASED RATE OF SEVERE MANIFESTATION IN MEN >50 YEARSDoerig, C. / Moulin, H. / Müllhaupt, B. / Pache, I. / Bihl, F. / Telenti, A. / Sahli, R. / Moradpour, D. et al. | 2014
- S303
-
P704 CLINICAL COURSE AND TREATMENT OF CHRONIC HEPATITIS E INFECTION IN PATIENTS AFTER SOLID ORGAN TRANSPLANTATIONHalilbasic, E. / Kazemi-Shirazi, L. / Staufer, K. / Munda, P. / Müller, C. J. / Holzmann, H. / Jaksch, P. / Klepetko, W. / Trauner, M. / Hofer, H. et al. | 2014
- S305
-
P710 EFFECT OF ALISPORIVIR (ALV) ON THE PHARMACOKINETICS (PK), SAFETY, AND TOLERABILITY OF METHADONE IN HEALTHY SUBJECTS AND OPIOID-DEPENDENT PATIENTS ON STABLE METHADONE MAINTENANCE THERAPY (MMT)Kovacs, S. J. / Ke, J. / Barve, A. / Webster, L. R. / Cheng, Y. / Zhang, J. / Maietta, R. / Sunkara, G. / Stein, D. S. et al. | 2014
- S306
-
P713 ELIGIBILITY 1: A PROSPECTIVE, OBSERVATIONAL, MULTICENTRE STUDY EVALUATING HCV PATIENTS CHARACTERISTICS OF ELIGIBILITY FOR ANTIVIRAL THERAPY IN REAL CLINICAL PRACTICEGamal, N. / Vukotic, R. / Andreone, P. et al. | 2014
- S309
-
P721 INTERFERON-STIMULATED GENE EXPRESSION IS ASSOCIATED WITH TREATMENT RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTIONDatsenko, Y. / Baum, P. / Schirmbeck, R. / Stern, J. O. / Sha, N. / Steinmann, G. G. et al. | 2014
- S310
-
P723 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIESAsselah, T. / Jensen, D. M. / Foster, G. R. / Sulkowski, M. S. / Ouzan, D. / Morano, L. / Buynak, R. / Agarwal, K. / Hassanein, T. / Forton, D. et al. | 2014
- S311
-
P725 IMPACT OF THE rs8099917 SNP ON SVR12 IN PATIENTS WITH HCV GT-1 INFECTION TREATED WITH FALDAPREVIR, DELEOBUVIR AND RIBAVIRINAsselah, T. / Zeuzem, S. / Soriano, V. / Bronowicki, J. P. / Lohse, A. W. / Müllhaupt, B. / Schuchmann, M. / Bourlière, M. / Buti, M. / Roberts, S. et al. | 2014
- S312
-
P729 HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES IN CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTORS OF RESPONSEMorisco, F. / Di Marco, V. / Granata, R. / Camera, S. / Ippolito, A. / Margaglione, M. / Fattovich, G. / Smedile, A. / Clery, E. / Ferraiuoli, C. et al. | 2014
- S314
-
P734 A SYSTEMATIC REVIEW OF INTERVENTIONS TO REDUCE ALCOHOL CONSUMPTION AMONG INDIVIDUALS WITH CHRONIC HCV INFECTIONDoyle, J. S. / Hunt, D. / Aspinall, E. J. / Hutchinson, S. J. / Goldberg, D. J. / Nguyen, T. / Falck-Ytter, Y. / Morgan, R. L. / Smith, B. / Stoove, M. et al. | 2014
- S316
-
P740 PHARMACOKINETICS OF FALDAPREVIR IN HEALTHY SUBJECTS FOLLOWING CO-ADMINISTRATION WITH ITRACONAZOLEMarzin, K. / Koenen, R. / Strelkowa, N. / Kammerer, K. P. / Elgadi, M. / Huang, F. et al. | 2014
- S318
-
P745 SEQUENCING OF INITIAL AND RECURRENT HCV INFECTIONS IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN (MSM)Macartney, M. / Ricciardi, A. / Rodger, A. / Webster, D. / Karageorgopoulos, D. / Fernandez, T. / Ferro, F. / Sasadeusz, J. / Bhagani, S. et al. | 2014
- S319
-
P746 VITAMIN D RELATED PATHWAY GENE POLYMORPHISMS ENHANCED THE PREDICTION OF TREATMENT RESPONSE IN ASIAN CHRONIC HEPATITIS C-INFECTED PATIENTS WITH UNFAVORABLE IL-28B rs12979860 GENOTYPESThanapirom, K. / Suksawatamnuay, S. / Sukeepaisarnjaroen, W. / Tangkijvanich, P. / Treeprasertsuk, S. / Thaimai, P. / Akkarathamrongsin, S. / Poovorawan, Y. / Kullavanijaya, P. / Komolmit, P. et al. | 2014
- S320
-
P749 HIGH BURDEN OF FIBROSIS AND METABOLIC COFACTORS IN A COHORT OF PREDOMINANTLY GENOTYPE 3-INFECTED INJECTION DRUG USERS IN SOUTHERN INDIAMehta, S. H. / Solomon, S. S. / Srikrishnan, A. K. / McFall, A. / Bose, K. / Nandagopal, P. / Anand, S. / Kumar, M. S. / Thomas, D. L. / Solomon, S. et al. | 2014
- S321
-
P752 GENETIC POLYMORPHISM IN PNPLA3 GENE IMPACTS DISEASE PROGRESSION AND HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS CKurosaki, M. / Tsuchiya, K. / Yasui, Y. / Tamaki, N. / Matsuda, S. / Hattori, K. / Izumi, N. et al. | 2014
- S323
-
P759 CD100 EXPRESSION ON B CELLS IS ASSOCIATED WITH CONTROL OF HEPATITIS C VIRUS INFECTIONGuo, Y. H. / He, Y. / Chen, L. / Zhou, Y. / Fan, C. / Zhang, Y. / Lian, J. Q. / Hao, C. Q. / Jia, Z. S. et al. | 2014
- S324
-
P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADAJacka, B. / Applegate, T. / Poon, A. F. / Harrigan, R. / Dore, G. J. / Olmstead, A. / DeBeck, K. / Milloy, M. J. / Lamoury, F. / Woods, C. et al. | 2014
- S325
-
P765 DRIED BLOOD SPOTS (DBS), A PROMISING TOOL FOR LARGE-SCALE HEPATITIS C SCREENING, DIAGNOSIS AND TREATMENT MONITORINGChevaliez, S. / Soulier, A. / Poiteau, L. / Pawlotsky, J. M. et al. | 2014
- S327
-
P772 CD14+ MONOCYTES AND CD163+ MACROPHAGES CORRELATE WITH THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS CZhao, S. / Wang, R. / Zhang, Y. / Meng, P. / Kong, L. / Nan, Y. et al. | 2014
- S328
-
P775 HEPATITIS C VIRUS INFECTION AND THE ASSOCIATED RISK FOR DIABETES MELLITUSShaw, G. T. / Lee, M. H. / Yang, H. I. / Jen, C. L. / Lu, S. N. / Wang, L. Y. / You, S. L. / LItalien, G. / Yuan, Y. / Chen, C. J. et al. | 2014
- S329
-
P778 RESOURCE UTILIZATION DURING HEPATITIS C TREATMENT WITH BOCEPREVIR- OR TELAPREVIR-BASED TRIPLE THERAPY VS DUAL THERAPY IN A LARGE U.S. HEALTH MAINTENANCE ORGANIZATIONNyberg, L. M. / Chiang, K. M. / Li, Z. / Nyberg, A. H. / Younossi, Z. M. / Cheetham, T. C. et al. | 2014
- S331
-
P784 INTERLEUKIN-18 AND ITS GENE POLYMORPHISMS INFLUENCE THE PROGRESSION OF CHRONIC HEPATITIS CSaid, E. M. / Soliman, M. S. / Rashed, M. S. / Abo El Azm, A. A. / Zakaria, R. / Abd El Salam, F. M. et al. | 2014
- S333
-
P790 REDUCING THE DISEASE BURDEN OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ENGLANDRosenberg, W. M. / Cramp, M. / Davis, M. / Parkes, J. / Ryder, S. / Razavi, H. / Hindman, S. et al. | 2014
- S334
-
P793 VALIDATION OF FATTY LIVER INDEX FOR IDENTIFYING FATTY LIVER IN A LARGE-SCALE CROSS-SECTIONAL STUDY IN POPULATIONS SEEKING CHECK-UP IN TAIWANSu, C. W. / Wang, Y. J. / Wu, J. C. / Huo, T. I. / Huang, Y. H. / Lee, K. C. / Lin, H. C. / Lee, F. Y. / Lee, S. D. et al. | 2014
- S336
-
P800 A CLOSE ASSOCIATION BETWEEN LOCALIZATION OF OXIDIZED PHOSPHOLIPIDS AND EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA IN LIVERS OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEIkura, Y. / Iwai, Y. / Muragaki, Y. et al. | 2014
- S338
-
P804 ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ESTIMATED GLOMERULAR FILTRATION RATE IN APPARENTLY HEALTHY POPULATIONShen, Z. / Qin, Y. / Zhu, H. / Yu, C. / Li, Y. et al. | 2014
- S339
-
P807 EVALUATION OF THE FATTY LIVER INDEX (FLI) IN A MULTIETHNIC UNITED STATES POPULATIONRuhl, C. E. / Everhart, J. E. et al. | 2014
- S340
-
P809 PATIENTS WITH T2DM ACCOMPANYING SEVERE DEGREE OF NAFLD ASSESSED BY CONTROLLED ATTENUATION PARAMETER USING FIBROSCANChon, Y. E. / Kim, K. / Jung, K. S. / Kim, S. U. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Chon, C. Y. / Han, K. H. et al. | 2014
- S341
-
P813 MODERATE ALCOHOL CONSUMPTION HAS A PROTECTIVE EFFECT ON INSULIN RESISTANCE IN NON-OBESE HEPATITIS C-INFECTED PATIENTSBurman, B. E. / Khalili, M. et al. | 2014
- S342
-
P816 MERTK rs4374383 AA GENOTYPE IS ASSOCIATED WITH A LOWER PREVALENCE OF SEVERE HEPATIC STEATOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASEPetta, S. / Valenti, L. / Grimaudo, S. / Tripodo, C. / Cammà, C. / Di Marco, V. / Dongiovanni, P. / Fargion, S. / Guarnotta, C. / Gulino, A. et al. | 2014
- S343
-
P819 PREDICTIVE FACTORS OF SIGNIFICANT STEATOSIS IN POTENTIAL HEALTHY LIVER DONORSJothimani, D. / Srivatsav, M. / Reddy, S. / Rela, M. et al. | 2014
- S344
-
P822 MULTIPARAMETRIC MAGNETIC RESONANCE SHOWS THAT OBESITY IS STRONGLY ASSOCIATED WITH HEPATIC STEATOSIS IN ADULTS AND CHILDREN AND CAN DIFFERENTIATE PATIENTS WITH NASH FROM NAFLDBanerjee, R. / Rial, B. / Pavlides, M. / Osuchukwu, C. / Lewandowski, A. J. / Collier, J. D. / Schneider, J. E. / Neubauer, S. / Barnes, E. et al. | 2014
- S345
-
P824 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASEKazankov, K. / Barrera, F. / Møller, H. J. / Vilstrup, H. / George, J. / Grønbæk, H. et al. | 2014
- S346
-
P828 THE COMMON PNPLA3 VARIANT IS ASSOCIATED WITH HEPATIC STEATOSIS QUANTIFIED BY CONTROLLED ATTENUATION PARAMETER AND DETERMINES THE FATE OF PATIENTS WITH CHRONIC LIVER DISEASESArslanow, A. / Stokes, C. S. / Weber, S. N. / Grünhage, F. / Lammert, F. / Krawczyk, M. et al. | 2014
- S347
-
P831 MAGNETIC RESONANCE IMAGING ALLOWS QUANTITATION OF HEPATIC TRIGLYCERIDE CONCENTRATION IN HUMANSJiménez-Agüero, R. / Emparanza, J. I. / Beguiristain, A. / Bujanda, L. / Alustiza, J. M. / García, E. / Hijona, E. / Gallego, L. / Sánchez, J. / Perugorria, M. et al. | 2014
- S348
-
P833 QUERCETIN MODULATES LIPIDS DROPLETS IN Huh7 CELLS BEARING PNPLA3 GENOTYPE GGRojas, A. / Rancha, I. / García-Valdecasas, M. / Del Campo, J. A. / Clement, S. / Negro, F. / Romero-Gomez, M. et al. | 2014
- S349
-
P834 NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASEGallego-Durán, R. / Cerro-Salido, P. / Pareja, M. J. / Ranchal, I. / Rico, M. C. / Rojas, L. / Aznar, R. / Bugianesi, E. / Crespo, J. / Arias-Loste, M. T. et al. | 2014
- S350
-
P837 GENOTYPE 3 AND CIRCULATING SCCA-IgM ARE INDEPENDENTLY ASSOCIATED WITH HISTOLOGICAL FEATURES OF NASH IN HCV INFECTED PATIENTSMartini, A. / Fattovich, G. / Guido, M. / Bugianesi, E. / Biasiolo, A. / Ieluzzi, D. / Gallotta, A. / Fassina, G. / Merkel, C. / Gatta, A. et al. | 2014
- S352
-
P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLDVanni, E. / Mezzabotta, L. / Rosso, C. / Gaggini, M. / Gambino, R. / Salomone, F. / Buzzigoli, E. / Saponaro, C. / Saba, F. / Ciociaro, D. et al. | 2014
- S353
-
P846 SERUM FREE FATTY ACID COMPOSITION IS ASSOCIATED WITH DIFFERENT DEGREES OF FIBROSISGambino, R. / Alemanno, N. / Pinach, S. / Saba, F. / Mezzabotta, L. / Rosso, C. / Vanni, E. / Bugianesi, E. / Cassader, M. et al. | 2014
- S354
-
P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTSSaponaro, C. / Vanni, E. / Gaggini, M. / Rosso, C. / Mezzabotta, L. / Gambino, R. / Buzzigoli, E. / Carli, F. / Abate, M. L. / Saba, F. et al. | 2014
- S355
-
P852 WHY GGT LEVELS SHOULDNT BE DISREGARDED WHEN CONSIDERING A PATIENT WITH POSSIBLE NAFLDBarsic, N. / Radic, D. / Marusic, Z. / Palcic, M. G. / Stojsavljevic, S. / Duvnjak, M. et al. | 2014
- S357
-
P857 A NEW INDEX OF GLUTATHIONE TURNOVER (GSH_TI) AND ITS ASSOCIATION WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Gaggini, M. / Saponaro, C. / Vanni, E. / Rosso, C. / Carli, F. / Buzzigoli, E. / Abate, M. L. / Ciociaro, D. / Mezzabotta, L. / Gambino, R. et al. | 2014
- S358
-
P860 NUCLEAR RECEPTOR FXR UPREGULATES GENE EXPRESSION OF BILE ACID TRANSPORTERS IN NONALCOHOLIC STEATOHEPATITISMéndez-Sánchez, N. / Sánchez-Valle, V. / López-Velázquez, J. A. / Chablé-Montero, F. / Chávez-Tapia, N. C. / Uribe, M. et al. | 2014
- S362
-
P867 FACTORS PREDICTING OUTCOME OF PATIENTS WITH ACUTE LIVER FAILURE MEETING THE CRITERIA OF LIVER TRANSPLANTATION: IMPACT OF ALBUMIN DIALYSIS WITH MARSSaliba, F. / Dahlqvist, G. / Letierce, A. / Ichai, P. / Ruiz, I. / Boudon, M. / Samuel, D. et al. | 2014
- S363
-
P871 SIGNIFICANTLY INCREASED POST-LIVER TRANSPLANTATION MORTALITY AMONG PATIENTS AGE 70 YEARS AND OLDERWong, R. J. / Ahmed, A. / Esquivel, C. et al. | 2014
- S364
-
P873 EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION IS ASSOCIATED WITH REDUCED GRAFT AND PATIENT SURVIVALBhanji, R. / Ma, M. / Bain, V. G. / Montano-Loza, A. J. et al. | 2014
- S365
-
P877 INCREASED GRAFT FAILURE WITH DONATION AFTER CARDIAC DEATH VERSUS DONATION AFTER BRAIN DEATH GRAFTS IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C: AN UPDATED META-ANALYSISWells, M. / Janik, T. / Chandok, N. et al. | 2014
- S366
-
P880 TERTIARY CENTRE EXPERIENCE OF THE SAFETY AND EFFICACY OF ANTI-TNFS FOR ULCERATIVE COLITIS (UC) AFTER LIVER TRANSPLANTATIONBarnabas, A. / Potts, J. / Agarwal, K. / Hayee, B. et al. | 2014
- S367
-
P882 COMBINED OR NOT COMBINED LIVER/KIDNEY TRANSPLANTATION FOR SYMPTOMATIC POLYCYSTIC LIVER DISEASE: SINGLE CENTER LONG-TERM OUTCOME EXPERIENCETemmerman, F. / Ceulemans, L. J. / Monbaliu, D. / Aerts, R. / van Pelt, J. / Darius, T. / Kuypers, D. / Pirenne, J. / Nevens, F. et al. | 2014
- S368
-
P884 DONOR/RECIPIENT GENDER MISMATCH MODIFIES THE IMPACT OF DONOR AGE ON GRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATIONBitetto, D. / Pecere, S. / Gambato, M. / Ferrarese, A. / Pasulo, L. / Lucà, M. G. / Poli, E. / Corradini, S. G. / Baccarani, U. / Burra, P. et al. | 2014
- S369
-
P886 RELEVANCE OF CHRONIC HEPATITIS E IN LIVER TRANSPLANT RECIPIENTS: A REAL-LIFE-SETTINGGalante, A. / Pischke, S. / Lang, M. / Lütgehetmann, M. / Polywka, S. / Nashan, B. / Lohse, A. W. / Sterneck, M. et al. | 2014
- S370
-
P889 NEW NUCLEOS(T)IDE ANALOGUE MONOPROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATIONCholongitas, E. / Goulis, J. / Antoniadis, N. / Fouzas, I. / Imvrios, G. / Vasiliadis, T. / Papanikolaou, V. / Akriviadis, E. et al. | 2014
- S371
-
P892 PREVALENCE OF DONOR SPECIFIC ANTIBODIES IN LIVER TRANSPLANTATION RECIPIENTS WITH UNEXPLAINED LIVER GRAFT ABNORMALITIES IS SIGNIFICANTLY HIGHER THAN IN CONTROL GROUPSGhandir, A. / Carmagnat, M. / Zafrani, E. S. / Roudot-Thoraval, F. / Hurtova, M. / Mallat, A. / Desvaux, D. / Féray, C. / Suberbielle, C. / Duvoux, C. et al. | 2014
- S372
-
P895 MODEL TO PREDICT RECURRENCE AFTER LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA BEYOND THE MILAN CRITERIALee, J. H. / Cho, Y. / Lee, D. H. / Lee, Y. B. / Yu, S. J. / Yi, N. J. / Lee, K. W. / Kim, S. H. / Kim, Y. J. / Yoon, J. H. et al. | 2014
- S373
-
P897 THE PREDICTORS OF TRANSPLANT FREE SURVIVAL IN FULMINANT AUTOIMMUNE ACUTE LIVER FAILURE: THE ACUTE LIVER FAILURE STUDY GROUP EXPERIENCEGanger, D. / Stravitz, R. T. / Reddy, K. R. / Battenhouse, H. / Speiser, J. / Lominadze, Z. / Lee, W. et al. | 2014
- S374
-
P900 LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS WITH RESPECT TO ALCOHOL RELAPSE AND LONG-TERM OUTCOMEBerlakovich, G. A. / Kollmann, D. / Rasoul-Rockenschaub, S. / Freundorfer, E. / Gyoeri, G. / Silberhumer, G. / Muehlbacher, F. / Soliman, T. et al. | 2014
- S375
-
P903 CONTROL OF DIABETES MELLITUS (DM) IN LIVER TRANSPLANT RECIPIENTS (LTR)Rodríguez-Medina, B. / Satorres, C. / Álvarez, D. / Herrero, I. / Serrano, T. / De la Mata, M. / Aguilera, V. / Rubín, . / Berenguer, M. et al. | 2014
- S376
-
P905 THE RISK OF DELISTING OR DEATH IN LIVER TRANSPLANT CANDIDATES INCREASES FOLLOWING INFECTIONS: RESULTS FROM THE NACSELD CONSORTIUMOLeary, J. G. / Bajaj, J. S. / Wong, F. / Kamath, P. S. / Biggins, S. W. / Patton, H. M. / Fallon, M. B. / Garcia-Tsao, G. / Subramanian, R. M. / Maliakkal, B. J. et al. | 2014
- S377
-
P908 EVEROLIMUS TREATMENT IN LIVER TRANSPLANTATION ACCORDING TO CLINICAL PRACTICE: A SPANISH MULTICENTRE COHORTCastroagudín, J. / Salcedo, M. / Bilbao, I. / Gómez, M. A. / Jimenez, C. / Fabregat, J. / Almohalla, C. / Herrero, I. / Cuervas-Mons, V. / Otero, A. et al. | 2014
- S378
-
P911 GLOMERULAR FILTRATION RATE DETERMINED BY CKD-EPI-CYSTATIN C EQUATION, BUT NOT WITH MDRD4 OR CKD-EPI-CREATININ, IS ASSOCIATED WITH LONG TERM SURVIVAL AFTER LIVER TRANSPLANTATIONUguen, T. / Jezequel, C. / Houssel, P. / Latournerie, M. / Boudjema, K. / Guyader, D. / Bardou-Jacquet, E. et al. | 2014
- S379
-
P914 MICROBIOLOGICAL ANALYSIS OF BILE DURING CHOLANGIOGRAPHY IN LIVER TRANSPLANT RECIPIENTS AND ITS IMPACT ON THE MANAGEMENT OF INFECTIOUS COMPLICATIONSHüsing, A. / Beckebaum, S. / Cicinnati, V. R. / Wilms, C. / Maschmeier, M. / Schmidt, H. H. / Kabar, I. et al. | 2014
- S380
-
P917 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCEStradella, D. / Risso, A. / Martini, S. / Rizzetto, M. / Salizzoni, M. et al. | 2014
- S381
-
P920 DOES PRE-TRANSPLANT ADRENAL FUNCTION HAVE AN IMPACT ON POST-TRANSPLANT RENAL FUNCTION?Saffioti, F. / Theocharidou, E. / OBeirne, J. / Agarwal, B. / Thorburn, D. / Jeffrey, G. / Burroughs, A. K. et al. | 2014
- S382
-
P923 RETROSPECTIVE STUDY COMPARING SAFETY AND EFFICACY OF GENERIC PREPARATION OF TACROLIMUS WITH PROGRAF AS PRIMARY IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATIONPasangulapati, S. / Featherstone, B. / Allison, M. E. et al. | 2014
- S383
-
P926 ASSOCIATION OF PRIMARY PAYER STATUS AND IN-HOSPITAL MORTALITY AMONG LIVER TRANSPLANT RECIPIENTS: A NATIONAL PERSPECTIVEMazumder, N. K. / Mujib, N. / Mujib, M. et al. | 2014
- S384
-
P929 HEPATIC FUNCTION AND DETERIORATION IN HEPATIC FUNCTION BY QUANTITATIVE LIVER-SPLEEN SCAN (QLSS) INDEPENDENTLY PREDICT CLINICAL EVENTS (CE): A SECONDARY ANALYSIS OF THE HALT-C TRIALHoefs, J. C. / Chen, W. P. / Gillen, D. et al. | 2014
- S385
-
P932 CIRRHOTIC CARDIOMYOPATHY MANIFESTED BY LEFT VENTRICULAR DIASTOLIC DYSFUNCTION (LVDD) – A RISK FACTOR IN THE DEVELOPMENT OF HEPATORENAL SYNDROME (HRS)Zaidi, Y. A. / Ali, B. / Salim, A. / Adil, M. / Alam, A. / Butt, A. K. / Malik, K. / Amin, J. / Dilshad, A. et al. | 2014
- S388
-
P941 REDUCTION IN SERUM SODIUM (Na) IN PATIENTS TREATED WITH TERLIPRESSIN FOR VARICEAL BLEEDING (VB) AND HEPATORENAL SYNDROME (HRS)Sugumaran, A. / Lougher, E. / Halpin-Evans, C. / Czajkowski, M. A. / Yeoman, A. D. et al. | 2014
- S389
-
P943 DIFFERENCES IN CREATININE BETWEEN GENDERS COULD DISADVANTAGE INFECTED CIRRHOTIC WOMEN: THE NACSELD EXPERIENCEBajaj, J. S. / OLeary, J. / Reddy, K. R. / Wong, F. / Fallon, M. / Biggins, S. / Patton, H. / Maliakkal, B. / Thuluvath, P. / Garcia-Tsao, G. et al. | 2014
- S390
-
P946 COMPARISON OF THE EFFICACY OF RIFAXIMIN VS NORFLOXACIN IN THE PREVENTION OF NOSOCOMIAL MULTIRESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSISRamos, J. M. / Vidal, I. / Bellot, P. / Francés, R. / González-Navajas, J. / Zapater, P. / Such, J. et al. | 2014
- S391
-
P949 QUANTITATION AND LOCATION OF THE SEVERITY OF BRAIN EDEMA IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE AND HEPATIC ENCEPHALOPATHYWeiss, N. / Rosselli, M. / Mouri, S. / Yu, D. / Galanaud, D. / Agarwal, B. / Thabut, D. / Jalan, R. et al. | 2014
- S392
-
P952 IODINATED CONTRAST IS NOT A RISK FACTOR FOR KIDNEY DYSFUNCTION IN STABLE CIRRHOTIC PATIENTS UNDERGOING ELECTIVE IMAGINGSafi, W. / Rauscher, I. / Umgelter, A. et al. | 2014
- S393
-
P955 IN VITRO COMPARISON OF Octaplas-LG, STANDARD Octaplas AND FRESH FROZEN PLASMA IN THE TREATMENT OF COAGULOPATHY DUE TO LIVER DISEASEConnaughton, M. A. / Chin, J. L. / Mc Cormack, P. A. / OBrien, P. / Fitzgerald, J. M. et al. | 2014
- S398
-
P971 VITAMIN K DOSING AND BRANCHED CHAIN AMINO ACIDS SUPPLEMENTATION COULD IMPROVE THE PROGNOSIS OF SORAFENIB-TREATED PATIENTS WITH HEPATOCELLULAR CARCINOMAHaruna, Y. / Inoue, A. et al. | 2014
- S401
-
P980 AN EXTERNAL VALIDATION OF THE HEPATOMA ARTERIAL-EMBOLISATION PROGNOSIS (HAP) SCORE: THE LIVERPOOL EXPERIENCENoorullah, O. / Lekharaju, V. P. / Din, I. U. / Klcova, J. / Cross, T. / Evans, J. / Sturgess, R. / Palmer, D. / Kumar, P. / OGrady, E. et al. | 2014
- S402
-
P983 VALIDATION OF THE HEPATOME ARTERIAL-EMBOLIZATION PROGNOSTIC (HAP)-SCORE IN AN AUSTRIAN TACE COHORTPinter, M. / Hucke, F. / Graziadei, I. / Vogel, W. / Trauner, M. / Sieghart, W. / Peck-Radosavljevic, M. et al. | 2014
- S405
-
P993 EASL AND MRECIST RESPONSE TO COMBINATION THERAPY OF SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION PREDICTS SURVIVAL IN HEPATOCELLULAR CARCINOMAWang, W. / Bai, W. / Zhao, Y. / Yin, Z. / He, C. / Niu, J. / Liu, L. / Chen, H. / Fan, D. / Han, G. et al. | 2014
- S406
-
P996 PROPOSAL FOR AN UPDATE OF THE BARCELONA STAGING SYSTEM FOR HEPATOCELLULAR CARCINOMA BASED ON THE ROLE OF PERFORMANCE STATUSPecorelli, A. / Vitale, A. / Venerandi, L. / Cucchetti, A. / Trevisani, F. / Bolondi, L. / Piscaglia, F. et al. | 2014
- S407
-
P999 Y90-RADIOEMBOLIZATION FOR INTERMEDIATE/ADVANCED HCC PATIENTS OUTSIDE THE CONVENTIONAL CRITERIA MAY BE DETRIMENTAL: A SINGLE CENTER EXPERIENCESposito, C. / Facciorusso, A. / Camerini, T. / Chiesa, C. / Maccauro, M. / Morosi, C. / Bhoori, S. / Citterio, D. / Mazzaferro, V. et al. | 2014
- S408
-
P1002 TREATMENT ALLOCATION AND SURVIVAL ACCORDING TO THE NEW BCLC-B SUB-CLASSIFICATION MODEL IN HEPATOCELLULAR CARCINOMA. EXPERIENCE IN A TERTIARY ROMANIAN GASTROENTEROLOGICAL AND SURGICAL CENTERSparchez, Z. A. / Radu, P. / Al Hajjar, N. / Iancu, C. et al. | 2014
- S409
-
P1005 TRANSIENT ELASTOGRAPHY BASED CIRRHOSIS SCORE SIGNIFICANTLY IMPROVING EFFICIENCY OF COMPENSATED HEPATITIS B CIRRHOSIS DETECTIONChen, Y. P. / Dai, L. / Peng, J. / Zhu, Y. F. et al. | 2014
- S411
-
P1011 ACOUSTIC RADIATION FORCE IMPULSE-IMAGING IN COMPARISON TO TRANSIENT ELASTOGRAPHY FOR NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS C: A PROSPECTIVE INTERNATIONAL MULTICENTER STUDYFriedrich-Rust, M. / Lupsor-Platon, M. / de Knegt, R. / Dries, V. / Buggisch, P. / Gebel, M. / Maier, B. / Herrmann, E. / Sagir, A. / Zachoval, R. et al. | 2014
- S412
-
P1013 MEASUREMENT OF LIVER AND SPLEEN STIFFNESS BY ARFI ELASTOGRAPHY: INTRA- AND INTER-OBSERVER VARIABILITY AND PREDICTORS OF VARIABILITYBalakrishnan, M. / Souza, F. / Munoz, C. / Augustin, S. / Loo, N. / Deng, Y. / Ciarleglio, M. / Garcia-Tsao, G. et al. | 2014
- S414
-
P1019 VALIDATION AND COMPARISON OF NON-INVASIVE MARKERS OF LIVER FIBROSIS IN WEST-AFRICAN PATIENTS WITH CHRONIC HEPATITIS B LIVING IN THE GAMBIALemoine, M. / Shimakawa, Y. / Goldin, R. / Khalil, M. / Lloyd, J. / Suso, P. / Nayagam, S. / Freeya Njai, H. / Taal, M. / Ndow, G. et al. | 2014
- S415
-
P1022 QUANTIFICATION OF FIBROSIS IN CHRONIC HEPATITIS C: PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND ACOUSTIC RADIATION FORCE IMPULSE USING COLLAGEN PROPORTIONATE AREA AS REFERENCECalvaruso, V. / Di Marco, V. / Bronte, F. / Bavetta, M. G. / Alessi, N. / Cammà, C. / Craxì, A. et al. | 2014
- S417
-
P1029 LIVER STIFFNESS (LS) ASSESSED WITH ACOUSTIC RADIATION FORCE IMPULSE (ARFI) CAN BE PROGNOSTIC FOR FIRST EPISODE OF ASCITES (AD) IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE (CLD)De Santis, A. / Bassanelli, C. / Lupo, M. / Iegri, C. / Di Ciesco, C. / Forlino, M. / Gallusi, G. / Attili, A. F. et al. | 2014
- S418
-
P1032 LOW ACCURACY OF NON-INVASIVE TESTS FOR ASSESSING RESIDUAL CIRRHOSIS IN HEPATITIS C PATIENTS WITH A SUSTAINED VIROLOGICAL RESPONSEDegasperi, E. / Grassi, E. / Fraquelli, M. / Aghemo, A. / DAmbrosio, R. / Colombo, M. et al. | 2014
- S419
-
P1034 ESTIMATED PREVALENCE OF HCV CIRRHOSIS IN THE CHRONIC HEPATITIS COHORT STUDY (CHECS)Gordon, S. C. / Lamerato, L. / Rupp, L. B. / Holmberg, S. D. / Moorman, A. C. / Spradling, P. R. / Teshale, E. / Vijayadeva, V. / Boscarino, J. A. / Schmidt, M. A. et al. | 2014
- S420
-
P1037 NON-INVASIVE MODALITIES FOR THE DIAGNOSIS OF ADVANCED FIBROSIS AND CIRRHOSIS IN CHRONIC HEPATITIS B OR CJeng, R. W. / Tsay, P. K. / Chen, W. T. / Huang, C. H. / Lin, S. M. / Tai, D. I. et al. | 2014
- S421
-
P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)Buti, M. / Morillas, R. / Manzano, M. L. / García-Retortillo, M. / Gutiérrez, M. L. / Martín, L. / Prieto, M. / Suárez, E. / Gea, F. / Rodríguez, M. et al. | 2014
- S423
-
P1045 ESTIMATING THE PROBABILITY OF RESPONSE TO PEG-INTERFERON THERAPY IN HBeAg-POSITIVE CHRONIC HEPATITIS B: THE EPIC-B STUDYSonneveld, M. J. / Wong, V. W. / Piratvisuth, T. / Jia, J. D. / Zeuzem, S. / Gane, E. / Liaw, Y. F. / Xie, Q. / Chan, H. L. / Hansen, B. E. et al. | 2014
- S424
-
P1047 ENTECAVIR EFFECTIVENESS IN NAIVE AND NUC EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B AND LIVER CIRRHOSIS: INTERIM ANALYSIS OF THE ITALIAN ENTAS COHORT STUDYPorro, E. / Di Leo, A. / Marzano, A. / Brancaccio, G. / Maimone, S. / Fasano, M. / Grasso, A. / Bronte, F. / Fagiuoli, S. / Santantonio, T. et al. | 2014
- S425
-
P1050 LONG-TERM OUTCOME OF SEQUENTIAL THERAPY WITH LAMIVUDINE FOLLOWED BY INTERFERON IN NUCLEOSIDE-NAIVE, HEPATITIS B E ANTIGEN-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B VIRUS GENOTYPE C INFECTIONEnomoto, M. / Nishiguchi, S. / Tamori, A. / Uchida-Kobayashi, S. / Iwai, S. / Morikawa, H. / Murakami, Y. / Jomura, H. / Shiomi, S. / Kawada, N. et al. | 2014
- S426
-
P1052 DETERMINANTS OF VARIABILITY IN ISG15 GENE EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) INFECTION DURING TREATMENT WITH ORAL TLR7 AGONIST GS-9620Gane, E. J. / Gordon, S. / Kottili, S. / Massetto, B. / Gaggar, A. / Stem, S. / Pflanz, S. / Ye, Z. / Subramanian, M. / McHutchison, J. G. et al. | 2014
- S427
-
P1054 NEED FOR EDUCATIONAL PROGRAMS AND SUPPORT DURING ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B IN IMMIGRANTS. EVIDENCE FROM THE CATALAN GIV-2002/2012-CHB THERAPEUTIC COHORTAcero Fernandez, D. / Ferri Iglesias, M. J. / López Nuñez, C. / Barenys Lacha, M. / Louvriex Freire, R. / Peñafiel Muñoz, J. / Fábregas Tió, S. / Lopez Oliu, C. / Vidal Plana, L. / Hombrados Verde, M. et al. | 2014
- S428
-
P1056 CHARACTERIZATION OF A NATURALLY OCCURRING REPLICATION-COMPETENT DEFECTIVE INTERFERING-LIKE HEPATITIS D VIRUS RNA LACKING BOTH RIBOZYME SITESHsu, C. W. / Chao, M. / Chen, Y. C. / Chang, M. L. / Huang, S. F. / Yeh, C. T. et al. | 2014
- S429
-
P1059 PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGSInvernizzi, F. / Lampertico, P. / Mangia, G. / Iavarone, M. / Viganò, M. / Primignani, M. / De Franchis, R. / Colombo, M. et al. | 2014
- S432
-
P1067 RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)Hou, J. / Ma, H. / Sun, J. / Xie, Q. / Xie, Y. / Sun, Y. / Wang, H. / Shi, G. / Wan, M. / Niu, J. et al. | 2014
- S433
-
P1070 FIRST LINE TREATMENT FOR CHRONIC HEPATITIS B (CH-B) IN REAL LIFE. AN ITALIAN MULTICENTER OBSERVATIONAL COHORT (HBV-RER)Borghi, V. / Andreone, P. / Massari, M. / Villa, E. / Pietrangelo, A. / Verucchi, G. / Levantesi, F. / Ferrari, C. et al. | 2014
- S434
-
P1073 PEGINTERFERON-INDUCED HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE AND SEROREVERSION IN CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON: A LONG-TERM FOLLOW-UP STUDYLuo, K. / Liu, Z. / He, H. / Yang, G. et al. | 2014
- S436
-
P1078 PREDICTION OF EVS PRESENCE BY CALCULATED RISK SCORES IN B-VIRAL CIRRHOSISMarietti, M. / Debernardi Venon, W. / Sciandrello, M. C. / Reggiani, S. / Fasulo, R. / Marengo, A. / Rizzetto, M. / Marzano, A. et al. | 2014
- S437
-
P1081 VACCINE ESCAPE MUTANTS AND SUBOPTIMAL HEPATITIS B VIRUS RESPONSE IN HIV–HBV COINFECTED PATIENTS FROM SUB-SAHARAN AFRICABoyd, A. / Moh, R. / Dény, P. / Issoufou, M. / Danel, C. / Anglaret, X. / Eholié, S. / Girard, P. M. / Zoulim, F. / Lacombe, K. et al. | 2014
- S438
-
P1084 PRESENCE OF STEATOSIS AND HBeAg-POSITIVE STATUS ARE INDEPENDENTLY ASSOCIATED WITH PERSISTENTLY ELEVATED SERUM ALT LEVELS IN CHRONIC HBV PATIENTS DURING ANTIVIRAL THERAPYJacobson, I. M. / Washington, M. K. / Thompson, A. / Afdhal, N. H. / Aguilar Schall, R. / Dinh, P. / Bornstein, J. / Flaherty, J. F. / Subramanian, G. M. / McHutchison, J. G. et al. | 2014
- S441
-
P1092 SEQUENTIAL THERAPY WITH TENOFOVIR AND PEGYLATED INTERFERON-ALPHA2b VERSUS TENOFOVIR MONOTHERAPY IN HBeAg POSITIVE CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSISJindal, A. / Kumar, M. / Sarin, S. K. et al. | 2014
- S442
-
P1095 HBVRNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD)van Bömmel, F. / van Bömmel, A. / He, H. / Wat, C. / Deichsel, D. / Berg, T. / Böhm, S. et al. | 2014
- S445
-
P1103 IMPACT OF THE LOW-DENSITY LIPOPROTEIN CHOLESTEROL ON RESPONSE TO TELAPREVIR-BASED TRIPLE THERAPY FOR CHRONIC HEPATITIS C PATIENTSOgawa, E. / Furusyo, N. / Nakamuta, M. / Kajiwara, E. / Nomura, H. / Dohmen, K. / Takahashi, K. / Satoh, T. / Azuma, K. / Kawano, A. et al. | 2014
- S446
-
P1107 TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUSEl-Dosouky, I. / ElHawari, S. / Emara, M. / Hamed, E. et al. | 2014
- S448
-
P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIALGuyader, D. / Bellissant, E. / Asselah, T. / Bronowicki, J. P. / Abergel, A. / Lasser, L. / Tran, A. / Bourlière, M. / Samuel, D. / Wartelle, C. et al. | 2014
- S449
-
P1114 PATIENT-REPORTED OUTCOMES (PROS) IN CHRONIC HEPATITIS C PATIENTS WITH CIRRHOSIS TREATED WITH SOFOSBUVIR (SOF) CONTAINING REGIMENSYounossi, Z. M. / Stepanova, M. / Nader, F. / Nelson, D. / Lawitz, E. / Jacobson, I. M. / Gane, E. / Hunt, S. L. et al. | 2014
- S450
-
P1117 SIMEPREVIR REDUCES TIME WITH PEGINTERFERON/RIBAVIRIN-INDUCED SYMPTOMS AND QUALITY-OF-LIFE IMPAIRMENTS: 72-WEEK RESULTS FROM THREE PHASE III STUDIESScott, J. / Gilles, L. / Peeters, M. / Cerri, K. / Beumont-Mauviel, M. et al. | 2014
- S452
-
P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALSFerenci, P. / Dieterich, D. / Zeuzem, S. / Mantry, P. / Sarrazin, C. / Crespo, J. / Tam, E. / Dufour, J. F. / Yoshida, E. M. / Nishiguchi, S. et al. | 2014
- S453
-
P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDYFerenci, P. / Flisiak, R. / Caruntu, F. A. / Lengyel, G. / Hohmann, M. / Bakalos, G. et al. | 2014
- S454
-
P1125 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: A POOLED ANALYSIS OF TWO PHASE III TRIALSFoster, G. R. / Cooper, C. / Dieterich, D. / Ferenci, P. / Crespo, J. / Diago, M. / Dufour, J. F. / Lee, W. M. / Maevskaya, M. / Müllhaupt, B. et al. | 2014
- S457
-
P1130 FUTILITY TESTING AT TREATMENT WEEK 8 IN PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 INFECTION RECEIVING BOCEPREVIR: A POST HOC ANALYSISJacobson, I. M. / Silva, M. / Bruno, S. / Calleja, J. L. / Bacon, B. / Esteban, R. / Poordad, F. / Bronowicki, J. P. / Sulkowski, M. S. / Vierling, J. M. et al. | 2014
- S458
-
P1132 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION WITH PRIOR RELAPSEAsselah, T. / Zehnter, E. / Agarwal, K. / Sakai, Y. / Yatsuhashi, H. / Willems, B. / Wright, D. / Calinas, F. / Calleja, J. L. / Negro, F. et al. | 2014
- S459
-
P1134 DURATION OF UNDETECTABLE HCVRNA IN PATIENTS TREATED WITH FALDAPREVIR–DELEOBUVIR INTERFERON-FREE COMBINATION IS ASSOCIATED WITH SVRDufour, J. F. / Zeuzem, S. / Buti, M. / Bronowicki, J. P. / Buynak, R. / Müllhaupt, B. / Mantry, P. / Bourlière, M. / Taunk, J. / Stern, J. O. et al. | 2014
- S460
-
P1136 TRIPLE THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING: IS IT POSSIBLE TO ACHIEVE SVR RATES COMPARABLE TO PIVOTAL TRIALS?Buggisch, P. / Schober, A. / Bruch, H. R. / Antoni, C. / Loehr, H. / Herrmann, A. / Steffens, H. / Moog, G. / Haessner, J. / Hoerster, H. G. et al. | 2014
- S462
-
P1141 SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV TREATMENT-EXPERIENCED PATIENTS AFTER TRIPLE THERAPY WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTINGBoeker, K. H. / Link, R. / Baumgarten, A. / Stoehr, A. / Heyne, R. / Roessle, M. / Schott, E. / Ullrich, R. / Erren, P. / Herold, C. et al. | 2014
- S463
-
P1144 DETERMINING THE COMPARATIVE EFFECTIVENESS OF EMERGING TREATMENT REGIMENS FOR HEPATITIS C VIRUS (HCV) INFECTION FROM SINGLE ARM PHASE III TRIALSQuintana, M. / Broglio, K. / Daar, E. S. / Yuan, Y. / Kalsekar, A. / Detry, M. A. / Lewis, R. J. / Le, T. / Berry, S. M. et al. | 2014
- S464
-
P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDYStahmeyer, J. T. / Rossol, S. / Bert, F. / Abdelfattah, A. M. / Mauss, S. / Heyne, R. / John, C. / Pape, S. / Schober, A. / Teuber, G. et al. | 2014
- S465
-
P1149 PHYSICIAN ADHERENCE TO AND EFFICACY OF TRIPLE THERAPY WITH TELAPREVIR (TVR) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN (PEGIFN/RBV) IN A REAL-LIFE SETTINGMauss, S. / Schober, A. / John, C. / Lutz, T. / Moog, G. / Bruch, H. R. / Teuber, G. / Christensen, S. / Heyne, R. / Pape, S. et al. | 2014
- S468
-
P1156 DACLATASVIR, ASUNAPREVIR, AND BMS-791325 IN A FIXED-DOSE COMBINATION: A PHASE 1 BIOAVAILABILITY STUDY IN HEALTHY VOLUNTEERSAdamczyk, R. / Sims, K. / Chang, I. / Filoramo, D. / Pursley, J. / Charlton, S. / Koo, O. / Bertz, R. / Rege, B. / AbuTarif, M. et al. | 2014
- S472
-
P1165 STANDARD INTERFERON – DOWN BUT NOT OUTChoudhry, A. A. / Alam, A. / Nawaz, A. A. / Riaz, M. / Yousaf, I. / Alvi, A. et al. | 2014
- S473
-
P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIAMilazzo, L. / Landonio, S. / Magni, C. / Gervasoni, C. / Calvi, E. / Cheli, S. / Clementi, E. / Galli, M. / Falvella, F. S. et al. | 2014
- S475
-
P1173 THE IMPACT OF HIV CO-INFECTION ON RATES AND SEVERITY OF ANEMIA OCCURRING DURING TREATMENT WITH SOFOSBUVIR-CONTAINING HCV REGIMENS: A POOLED ANALYSISNaggie, S. / Sulkowski, M. / Gaggar, A. / Stamm, L. / Ni, L. / Brainard, D. / Symonds, W. / McHutchison, J. / Dieterich, D. / Rodriguez-Torres, M. et al. | 2014
- S478
-
P1180 CAN A LIFESTYLE MODIFICATION INTERVENTION IMPROVE RISK FACTORS FOR A NEGATIVE RESPONSE TO PEGINTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND OBESITY?Agarwal, A. / Pattullo, V. / Garcia-Saenz-de-Sicilia, M. / Sockalingam, S. / Fantus, I. G. / Allard, J. P. / Heathcote, E. J. / Feld, J. J. / Duarte-Rojo, A. et al. | 2014
- S479
-
P1182 RELATIONSHIP OF LEPTIN AND ADIPONECTIN LEVELS WITH EXPRESSION OF ADR1 AND ADR2, VIRAL LOAD AND INFECTING HCV-GENOTYPE IN MEXICAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTIONRincon-Sanchez, A. R. / Rios-Guerra, M. A. / Cordero Perez, P. / Muñoz Espinosa, L. E. / Islas-Carbajal, M. C. / Rivs-Estilla, A. M. et al. | 2014
- S481
-
P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDYForns, X. / Samuel, D. / Mutimer, D. / Fagiouli, S. / Navasa, M. / Agarwal, K. / Berenguer, M. / Colombo, M. / Herzer, K. / Nevens, F. et al. | 2014
- S482
-
P1189 HIGH MIG (CXCL9) PLASMA LEVEL FAVORS RESPONSE TO PEGINTERFERON AND RIBAVIRIN IN HCV INFECTED PATIENTS BUT IS NOT LINKED TO DPP4 ACTIVITYJohansson, S. / Talloen, W. / Tuefferd, M. / Darling, J. / Fanning, G. / Fried, M. W. / Aerssens, J. et al. | 2014
- S483
-
P1192 HEPATITIS C VIRUS (HCV) RELATED KNOWLEDGE AND WILLINGNESS TO RECEIVE TREATMENT AMONG PATIENTS ON METHADONE MAINTENANCEZeremski, M. / Dimova, R. B. / Zavala, R. / Kritz, S. / Lin, M. / Smith, B. D. / Zibbell, J. / Talal, A. H. et al. | 2014
- S484
-
P1194 EVALUATION OF OPTIMAL HCV RNA CUT-OFFS WITH TWO MAJOR REAL-TIME PCR-BASED ASSAYS FOR RESPONSE-GUIDED TRIPLE THERAPY WITH TELAPREVIRSarrazin, C. / Dierynck, I. / Cloherty, G. / Ghys, A. / Janssen, K. / Van Eygen, V. / Luo, D. / Witek, J. / Buti, M. / Picchio, G. et al. | 2014
- S485
-
P1196 ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSISSalmerón, J. / Pons, J. / Quiles, R. / Pascasio, J. / Carmona, I. / Simón, M. / Gila, A. / Sánchez Antolín, G. / Sousa, J. / Serra, M. et al. | 2014
- S486
-
P1198 EFFECTIVENESS OF TRIPLE THERAPY IN CLINICAL PRACTICE FOR TREATMENT-NAIVE HCV PATIENTS WITH ADVANCED HEPATIC FIBROSIS. VIROLOGIC RESPONSE DATA AT 12 WEEKS POST-TREATMENT (SVR-12W)Prieto, M. / Pascasio, J. / Vinaixa, C. / Gila, A. / Serra, M. / Ruiz Escolano, E. / Cuaresma, M. / Urquijo, J. / Millán, R. / Sánchez Ruano, J. et al. | 2014
- S488
-
P1202 EARLY PREDICTION OF SUSTAINED VIROLOGIC RESPONSE BY HCV CORE ANTIGEN KINETICS IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON PLUS RIBAVIRINRicco, G. / Moriconi, F. / Colombatto, P. / Oliveri, F. / Cavallone, D. / Ciccorossi, P. / Coco, B. / Romagnoli, V. / Rastelli, C. / Cherubini, B. et al. | 2014
- S489
-
P1205 ELIGIBILITY 2: A PROSPECTIVE, OBSERVATIONAL, MULTICENTRE STUDY EVALUATING THE MANAGEMENT AND OUTCOMES OF PEG-INTERFERON/RIBAVIRIN (PEG-IFN/RBV) TREATMENT IN CHRONIC HEPATITIS C (CHC)Vukotic, R. / Gamal, N. / Andreone, P. et al. | 2014
- S490
-
P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKERPalescandolo, E. / Vijgen, L. / Talloen, W. / Colombo, M. / Mangia, A. / Wedemeyer, H. / Demasi, R. / Lonjon-Domanec, I. / Aerssens, J. et al. | 2014
- S491
-
P1210 PREDICTORS OF SVR24 FOR 1078 PATIENTS WITH SEVERE FIBROSIS OR COMPENSATED CIRRHOSIS: THE INTERNATIONAL TELAPREVIR ACCESS PROGRAMColombo, M. / Strasser, S. I. / Moreno, C. / Ferreira, P. A. / Urbanek, P. / Fernández, I. / Abdurakhmanov, D. / Streinu-Cercel, A. / Verheyen, A. / Iraqi, W. et al. | 2014
- S494
-
P1219 IMPACT OF IL-28B GENE POLYMORPHISM ON INTRAFAMILIAL TRANSMISSION, AND RESPONSE TO TREATMENT OF HCV. IS IT OF THE SAME IMPORTANCE?Elwan, N. M. / Assal, F. H. / AboAli, L. / Effat, L. / Sayed, K. / Shalaby, S. / Abdel-Hamid, M. et al. | 2014
- S495
-
P1222 A PHASE II STUDY OF SAMATASVIR (IDX719) IN COMBINATION WITH SIMEPREVIR AND RIBAVIRIN IN TREATMENT-NAÏVE HCV-INFECTED SUBJECTS WITH GENOTYPES 1B AND 4 (HELIX-1 STUDY)Lawitz, E. / Rodriguez-Torres, M. / Nguyen, T. / Sheikh, A. / Tobias, H. / Galati, J. / Hill, J. / Lok, A. / Nelson, D. / Dubuc Patrick, G. et al. | 2014
- S496
-
P1225 THE S282T VARIANT IS NOT OBSERVED IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 HCV INFECTION TREATED WITH THE NUCLEOTIDE INHIBITOR VX-135 IN COMBINATION WITH RIBAVIRINTigges, A. / Zhang, E. / Davis, A. / Spanks, J. / Dorrian, J. / Symons, J. / Bartels, D. / Fry, J. / Kieffer, T. et al. | 2014
- S497
-
P1228 COMPARATIVE RESISTANCE ANALYSIS BETWEEN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT EXPERIENCED PATIENTS WHO FAILED TREATMENT WITH A COMBINATION OF VANIPREVIR (MK-7009) AND PEGYLATED INTERFERON AND RIBAVIRIN (P/R)Ludmerer, S. / Barnard, R. / Brunhoffer, J. / Howe, A. / Hwang, P. M. / Liu, R. / Zhou, A. / Mobashery, N. et al. | 2014
- S498
-
P1231 TOO CERTAIN, TOO SOON? INTERPRETING RESULTS FROM EARLY-STAGE HCV CLINICAL TRIALSKing, M. / Xiong, J. et al. | 2014
- S500
-
P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORSCento, V. / Di Maio, V. C. / Di Paolo, D. / Micheli, V. / Tontodonati, M. / De Leonardis, F. / Aragri, M. / Antonucci, F. P. / Mancon, A. / Armenia, D. et al. | 2014
- S501
-
P1238 SVR24 RATE OF 60% IN HCV G1-INFECTED PRIOR NULL RESPONDERS TREATED WITH MERICITABINE (MCB), BOCEPREVIR (BOC) PLUS PEGIFN ALFA-2a/RIBAVIRIN (P/R): RESULTS FROM DYNAMO 1Wedemeyer, H. / Hézode, C. / Lee, S. S. / Scalori, A. / Zhao, S. / Voulgari, A. / Thommes, J. et al. | 2014
- S502
-
P1240 CHARACTERIZATION OF HCV-1 SUBTYPES AND NATURAL RESISTANCE TO PROTEASE INHIBITORS IN LIVER AND PLASMA COMPARTMENTS OF HIV/HCV COINFECTED INDIVIDUALSBagaglio, S. / Messina, E. / Hasson, H. / Merli, M. / Lazzarin, A. / Smacchia, A. / Uberti-Foppa, C. / Morsica, G. et al. | 2014
- S503
-
P1243 SOFOSBUVIR PLUS RIBAVIRIN, AN INTERFERON-FREE REGIMEN, IN THE TREATMENT OF TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC GENOTYPE 4 HCV INFECTIONRuane, P. J. / Ain, D. / Meshrekey, R. / Riad, J. / Soliman, M. / Mikhail, S. / Wolfe, P. R. / Kersey, K. / Doehle, B. / Jiang, D. et al. | 2014
- S504
-
P1246 PHLEBOTOMY FREQUENCY REDUCED BY PROTON PUMP INHIBITORS IN PATIENTS WITH HEREDITARY HEMOCHROMATOSISvan Aerts, R. M. / van Deursen, C. T. / Koek, G. H. et al. | 2014
- S506
-
P1252 EVEROLIMUS HALTS DISEASE PROGRESSION IN A RODENT MODEL OF POLYCYSTIC LIVER DISEASE: RESULTS OF A LONGITUDINAL MRI-STUDYTemmerman, F. / Chen, F. / van Pelt, J. / Mekahli, D. / Levtchenko, E. / Ni, Y. / Nevens, F. et al. | 2014
- S508
-
P1259 PROGNOSIS IN PEDIATRIC ACUTE LIVER FAILURE – PELD VERSUS PRISM III SCORESKhanna, R. / Sood, V. / Alam, S. / Rawat, D. et al. | 2014
- S509
-
P1262 TARGETED NEXT-GENERATION SEQUENCING (NGS) REVEALS NOVEL GENOTYPE AND PHENOTYPE CORRELATIONS FOR MITOCHONDRIAL DNA DEPLETION SYNDROMES IN PEDIATRIC ACUTE LIVER FAILURE (ALF)Valencia, A. C. / Huang, T. / Sheridan, R. / Peters, A. / Bove, K. / Wang, X. / Miethke, A. et al. | 2014
- S511
-
P1267 CLINICAL PRESENTATION OF CYSTIC FIBROSIS-ASSOCIATED LIVER DISEASE AFTER LUNG TRANSPLANTATIONStaufer, K. / Halilbasic, E. / Schick, S. / Harm, S. / Brichta, A. / Ba-Ssalamah, A. / Jaksch, P. / Klepetko, W. / Trauner, M. / Kazemi-Shirazi, L. et al. | 2014
- S512
-
P1270 SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVOGaruti, C. / Montosi, G. / Barelli, S. / Pietrangelo, A. / Corradini, E. et al. | 2014
- S513
-
P1273 DIRECT COSTS OF TREATMENT AND CATASTROPHIC HEALTH EXPENDITURE AMONG HBV-RELATED DISEASES AND THE ROLE OF PUBLIC HEALTH INSURANCE IN YUNNAN PROVINCE OF CHINAChe, Y. / Sriplung, H. / Chongsuvivatwong, V. / Li, L. / You, J. et al. | 2014
- S514
-
P1276 5 YEAR REVIEW OF NEWLY IDENTIFIED HEPATITIS B SURFACE ANTIGEN POSITIVE PATIENTS IN A SUBURBAN LONDON DISTRICT GENERAL HOSPITALNayagam, J. S. / Mullender, C. / See, L. M. / Gess, M. et al. | 2014
- S517
-
P1283 PREVALENCE OF LIVER DISEASES IN RUSSIAN MEGALOPOLISKomova, A. / Maevskaya, M. / Ivashkin, V. et al. | 2014
- S518
-
P1286 RAISING THE PROFILE OF END OF LIFE CARE NEEDS FOR PATIENTS DYING FROM LIVER DISEASE – USING NATIONAL MORTALITY DATAPring, A. J. / Verne, J. et al. | 2014
- S520
-
P1292 EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTIONValerio, H. M. / Hutchinson, S. J. / Goldberg, D. J. / Lewsey, J. / Weir, A. / Innes, H. et al. | 2014
- S523
-
O164 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-1 STUDYMangia, A. / Marcellin, P. / Kwo, P. / Foster, G. R. / Buti, M. / Bräu, N. / Muir, A. / Yang, J. C. / Mo, H. / Ding, X. et al. | 2014
- S524
-
O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTSManns, M. / Pol, S. / Jacobson, I. / Marcellin, P. / Gordon, S. / Peng, C. Y. / Chang, T. T. / Everson, G. / Heo, J. / Gerken, G. et al. | 2014
- S525
-
O168 THE FIRST PRIMARY BILIARY CIRRHOSIS (PBC) PHASE 3 TRIAL IN TWO DECADES – AN INTERNATIONAL STUDY OF THE FXR AGONIST OBETICHOLIC ACID IN PBC PATIENTSNevens, F. / Andreone, P. / Mazzella, G. / Strasser, S. / Bowlus, C. / Invernizzi, P. / Drenth, J. / Pockros, P. / Regula, J. / Hansen, B. et al. | 2014
- S527
-
P1300 EFFICACY AND SAFETY OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DCV+ASV) IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1B: RESULTS OF THE HALLMARK DUAL STUDYKao, J. H. / Heo, J. / Yoffe, B. / Sievert, W. / Jacobson, I. / Bessone, F. / Peng, C. Y. / Roberts, S. / Yoon, K. T. / Kopit, J. et al. | 2014
- S528
-
P1303 AN INTERFERON- AND RIBAVIRIN-FREE 12-WEEK REGIMEN OF ONCE-DAILY VX-135 AND DACLATASVIR IN TREATMENT-NAÏVE PATIENTS WITH GENOTYPE 1 HCV INFECTIONGane, E. / Stedman, C. / Garg, V. / George, S. / Kieffer, T. / Krop, J. / Lawal, A. / Lan, L. / Rubin, R. et al. | 2014
- S529
-
P1304 HEPATITIS C GENOTYPE 2–6 VIRUSES WITH PROTEASE SUBSTITUTIONS IMPLICATED IN GENOTYPE 1 RESISTANCE SHOW COMPLEX PATTERNS OF RESISTANCE TO 8 CLINICALLY RELEVANT PROTEASE INHIBITORSJensen, S. B. / Serre, S. B. / Li, Y. P. / Humes, D. G. / Ramirez, S. / Bukh, J. / Gottwein, J. M. et al. | 2014
- S530
-
P1307 IMPACT OF HYPOTHERMIC OXYGENATED MACHINE PERFUSION (HOPE) ON IMMUNE RESPONSE IN A RODENT MODEL OF LIVER TRANSPLANTATIONSchlegel, A. / Kron, P. / Graf, R. / Clavien, P. A. / Dutkowski, P. et al. | 2014
- S532
-
P1312 SOFOSBUVIR AND DACLATASVIR FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: POTENT ANTIVIRAL ACTIVITY BUT LACK OF CLINICAL BENEFIT IF TREATMENT IS GIVEN TOO LATEPellicelli, A. M. / Lionetti, R. / Montalbano, M. / Durand, C. / Ferenci, P. / DOffizi, G. / Knop, V. / Telese, A. / Lenci, I. / Andreoli, A. et al. | 2014
- S533
-
P1315 PRC1 IS UPREGULATED BY CTCF AND PROMOTES CELL PROLIFERATION IN HEPATOCELLULAR CARCINOMAZhang, B. / Ding, X. / Lv, Y. / Zhuge, Y. / Zhang, X. / Li, Y. / Wang, L. / Xu, G. / Zou, X. P. et al. | 2014
- S535
-
P1321 LONG TERM OUTCOMES AND PROGNOSTIC ANALYSIS OF SMALL HEPATOCELLULAR CARCINOMA TREATED WITH RADIOFREQUENCY ABLATION: 10 YEARS FOLLOW UP IN CHINESE PATIENTSZhang, L. / Chen, Y. / Ge, L. N. / Ren, G. Z. et al. | 2014
- S536
-
P1324 LEDIPASVIR (LDV) AND SOFOSBUVIR (SOF) COMBINATION IMPROVES PATIENT-REPORTED OUTCOMES (PRO) DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) PATIENTS: RESULTS FROM THE ION-1 CLINICAL TRIALYounossi, Z. / Stepanova, M. / Marcellin, P. / Afdhal, N. / Nader, F. / Hunt, S. et al. | 2014
- S539
-
Author index| 2014
- S591
-
Disclosures: no commercial relationships| 2014
- S597
-
Disclosures: commercial relationships| 2014
- xi
-
Contents| 2014
-
P538 ADHERENCE TO QUALITY OF CARE INDICATORS FOR CIRRHOSIS RELATED ASCITES IS ASSOCIATED WITH IMPROVED PATIENT OUTCOMESLe, S. / Spelman, T. / Heerasing, N. / Chong, C. P. / Lim, J. / He, T. / Sahhar, L. / Ha, P. / Sievert, W. et al. | 2014
-
P588 POPULATION TRENDS IN LIVER CANCER SURVIVAL OVER A 26-YEAR PERIODMacLachlan, J. H. / Carville, K. S. / Cowie, B. C. et al. | 2014
-
P606 THE ROLE OF TGF-β2 IN CHRONIC LIVER DISEASE (CLD) AND HEPATOCELLULAR CARCINOMA (HCC)Dropmann, A. / Dediulia, T. / Weber, S. / Abshagen, K. / Wieland, M. / Nittka, S. / Breitkopf-Heinlein, K. / Korhonen, H. / Jaschinski, F. / Janicot, M. et al. | 2014
-
P659 HEV SEROPREVALENCE IN 291 PATIENTS WITH CHRONIC LIVER DISEASE IN A GERMAN UNIVERSITY HOSPITALSchulz, M. / Schott, E. et al. | 2014
-
P696 A COMPLEX HBV QUASISPECIES IN RT AND HBsAg CHARACTERIZES PATIENTS WITH ACUTE HEPATITIS B: A REFINED UDPS ANALYSISAragri, M. / Coppola, N. / Alteri, C. / Minichini, C. / Battisti, A. / Sagnelli, C. / Bellocchi, M. C. / Pisaturo, M. A. / Salpini, R. / Starace, M. et al. | 2014
-
P703 THE GLOBAL BURDEN OF HEPATITIS A VIRUS IN 1990 AND 2005Rein, D. B. / Stevens, G. / Flaxman, A. / Wittenborn, J. S. / Timothy, N. / Wiktor, S. Z. / Wiersma, S. T. et al. | 2014
-
P718 ESTIMATING HEALTH STATUS USING EQ5D FOR CHRONIC HEPATITIS C (CH-C) PATIENTS TREATED WITH SOFOSBUVIR (SOF) CONTAINING REGIMENSYounossi, Z. M. / Stepanova, M. / Cure, S. / Bourhis, F. / Nader, F. / Hunt, S. L. et al. | 2014
-
P743 IMPACT OF BASELINE SERUM FERRITIN ON SURVIVAL OF PATIENTS WITH CHRONIC HEPATITIS C AFTER A 15 YEARS FOLLOW-UPJézéquel, C. / Bardou-Jacquet, E. / Désille, Y. / Renard, I. / Latournerie, M. / Houssel-Debry, P. / Le Gruyer, A. / Guillygomarch, A. / Le Lan, C. / Brissot, P. et al. | 2014
-
P741 PHASE ANGLE IS ASSOCIATED WITH ADVANCED FIBROSIS IN HCV PATIENTSDorna, M. S. / Costa, N. A. / Campos, L. F. / Romeiro, F. G. / Sassaki, L. Y. / Paiva, S. A. / Minicucci, M. F. / Silva, G. F. et al. | 2014
-
P751 DISTINCT VALUES OF LIVER STIFFNESS PREDICT PROGRESSION TO ADVANCED LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS CLabarga, P. / Fernandez-Montero, J. V. / Barreiro, P. / Vispo, M. E. / Sierra, R. / Perez, I. / de Mendoza, C. / Soriano, V. et al. | 2014
-
P796 NADPH OXIDASE (NOX 4) AND P22PHOX GENE POLYMORPHISMS ARE ASSOCIATED WITH HUMAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Rabelo, F. / Stefano, J. T. / Lima, R. V. / Seixas, M. / Patente, T. / Vanni, D. / Cavaleiro, A. M. / Mazo, D. C. / Carrilho, F. J. / Corrêa-Giannella, M. L. et al. | 2014
-
P815 REDUCTION OF DAILY CALORIC INTAKE SIGNIFICANTLY IMPROVES LIVER STEATOSIS AND OVERRIDES THE EFFECT OF THE PROSTEATOTIC PNPLA3 (ADIPONUTRIN) VARIANTKrawczyk, M. / Stachowska, E. / Lammert, F. / Milkiewicz, P. / Milkiewicz, M. et al. | 2014
-
P851 PREDIABETES CONTRIBUTES TO THE DEVELOPMENT OF FATTY LIVER: A LONGITUDINAL STUDYMoriya, A. / Iwasaki, Y. / Ohguchi, S. / Kayashima, E. / Mitsumune, T. / Taniguchi, H. / Ando, M. et al. | 2014
-
P868 CHANGE IN MELD AT 2 WEEKS AFTER ACUTE-ON-CHRONIC LIVER FAILURE AS INDICATOR OF MORTALITY AND LIVER TRANSPLANT AT 60 DAYSKumar, R. / Krishnamoorthy, T. L. / Tan, H. K. / Lui, H. F. / Chow, W. C. et al. | 2014
-
P878 MULTIVARIATE ANALYSIS OF FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE RATE OF PROTEASE INHIBITOR-BASED TREATMENT FOR RECURRENT HCV GENOTYPE 1 AFTER LIVER TRANSPLANTATION: MULTICENTER EXPERIENCEPungpapong, S. / Aqel, B. / Charlton, M. / Vargas, H. / Keaveny, A. et al. | 2014
-
P881 COGNITIVE IMPAIRMENT AND ELECTROENCEPHALOGRAPHIC ALTERATIONS BEFORE AND AFTER LIVER TRANSPLANTATION: WHAT IS REVERSIBLE?Campagna, F. / Montagnese, S. / Schiff, S. / Biancardi, A. / Mapelli, D. / Angeli, P. / Poci, C. / Cillo, U. / Merkel, C. / Gatta, A. et al. | 2014
-
P904 A NOVEL RISK SCORE TO PREDICT EARLY CARDIOVASCULAR MORTALITY FOLLOWING LIVER TRANSPLANTATIONVanWagner, L. B. / Lapin, B. / Levitsky, J. / Skaro, A. / Lloyd-Jones, D. et al. | 2014
-
P906 AZATHIOPRINE AND EARLY TACROLIMUS LEVELS <10 ng/mL ARE PROTECTIVE AGAINST PROGRESSIVE FIBROSIS IN RECURRENT HCV POST LTManousou, P. / Parisi, I. / Wijewantha, H. / Tsochatzis, E. / Samonakis, D. / Patch, D. / OBeirne, J. / Thorburn, D. / Dhillon, A. P. / Pinzani, M. et al. | 2014
-
P978 ESTABLISH A RISK SCORE SYSTEM COMPOSED OF SEROLOGICAL, PATHOLOGICAL AND TUMOR BIOLOGICAL PARAMETERS TO PREDICT POSTOPERATIVE HEPATOCELLULAR CARCINOMA RECURRENCEWu, J. C. / Su, C. W. / Chau, G. Y. et al. | 2014
-
P981 MODERN SURGICAL LIVER RESECTIONS OFFER BETTER RESULTS THAN TRANSARTERIAL CHEMOEMBOLIZATION IN CIRRHOTIC PATIENTS WITH B-BCLC STAGE HEPATOCELLULAR CARCINOMACiria, R. / Gallardo, A. B. / Cabrera, J. / Luque, A. / Ayllón, M. D. / Rodríguez-Perálvarez, M. / Montero, J. L. / López-Cillero, P. / de la Mata, M. / Briceno, J. et al. | 2014
-
P994 ANTIVIRAL THERAPY IMPROVES OUTCOMES IN PATIENTS WITH SMALL HEPATOCELLULAR CARCINOMA AND CHRONIC HEPATITIS C VIRUS INFECTION TREATED WITH RFAZhang, N. / Li, F. / Liu, J. / Kemmer, N. M. / Neff, G. / Lu, W. et al. | 2014
-
P1031 A SIMPLE FLUORESCENCE BASED METHOD TO NON-INVASIVELY IMAGE LIVER FIBROSISLuli, S. / Hill, S. / Wilson, C. L. / Wright, M. C. / Mann, D. A. / Oakley, F. et al. | 2014
-
P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST?Giannelli, V. / Di Gregorio, V. / Lucidi, C. / Iebba, V. / Santangelo, F. / Attili, A. F. / Riggio, O. / Schippa, S. / Merli, M. et al. | 2014
-
P45 SEQUENTIAL TRANSCRIPTOME ANALYSIS OF HUMAN HEPATOCARCINOGENESIS BY RNA SEQUENCING SUPPORTS INTENSIFIED SURVEILLANCE OF EARLY LESIONS TO PREVENT LATE STAGE ACQUISITION OF MALIGNANT TRAITSMarquardt, J. U. / Seo, D. / Andersen, J. B. / Gillen, M. C. / Kim, M. S. / Conner, E. C. / Galle, P. R. / Factor, V. M. / Park, Y. N. / Thorgeirsson, S. S. et al. | 2014
-
P59 YES-ASSOCIATED PROTEIN (YAP) IS REQUIRED FOR THE CLONAL EXPANSION OF PRENEOPLASTIC HEPATOCYTES AND OVAL CELL PROLIFERATIONKowalik, M. A. / Perra, A. / Ghiso, E. / Ledda-Columbano, G. M. / Giordano, S. / Columbano, A. et al. | 2014
-
P80 ANGIOGENESIS POLYMORPHISMS PROFILE IN THE PREDICTION OF CLINICAL OUTCOME OF ADVANCED HCC PATIENTS RECEIVING SORAFENIB: COMBINED ANALYSIS OF VEGF AND HIF-1α. THE ALICE-2 STUDYFaloppi, L. / Scartozzi, M. / DAnzeo, M. / Bianconi, M. / Svegliati Baroni, G. / Silvestris, N. / Gardini, A. C. / Masi, G. / Giampieri, R. / Del Prete, M. et al. | 2014
-
P107 HUMAN BILIARY TREE STEM/PROGENITOR CELLS (hbTSCS) FROM PERIBILIARY GLANDS (PBGS) OF ADULT LIVER DISPLAY IMMUNOMODULATORY PROPERTIES THROUGH Fas/Fas LIGAND INDUCED T-CELL LYMPHOCYTE APOPTOSISCarnevale, G. / Riccio, M. / Cardinale, V. / Gibelini, L. / De Biasi, S. / Pisciotta, A. / Carpino, G. / Gentile, R. / Berloco, P. B. / Brunelli, R. et al. | 2014
-
P104 ROLE OF TUMOR NECROSIS FACTOR-a DURING THE DUCTULAR REACTION IN MOUSE MODELS OF LIVER INJURYBest, J. / Verhulst, S. / Van Hul, N. / Syn, W. K. / Heindryckx, F. / Van Vlierberghe, H. / Reynaert, H. / Leclercq, I. A. / van Grunsven, L. A. / Dollé, L. et al. | 2014
-
P110 GENE EXPRESSION DURING HEPATOCYTE DIFFERENTIATION DRIVEN BY EPIGENETIC CHANGES: VIA PROMOTERS OR ENHANCERS?Vanhove, J. / Pistoni, M. / Welters, M. / Eggermont, K. / Vanslembrouck, V. / Collas, P. / Voncken, W. / Verfaillie, C. M. et al. | 2014
-
P115 EFFECT OF PURIFIED ALPHA 1-ANTITRYPSIN (AAT) ON EXPRESSION OF AAT IN NORMAL (PIMM) AND AAT DEFICIENT (PIZZ) PRIMARY HUMAN HEPATOCYTESEllis, E. C. / Johansson, H. / Zemack, H. / Jorns, C. / Gramignoli, R. / Strom, S. / Nowak, G. / Ericzon, B. G. et al. | 2014
-
P137 THE EXPRESSION OF NKG2D-LIGANDS BY ACTIVATED CD4 T CELLS RENDERS THEM SUSCEPTIBLE TO NK CELL REGULATION IN CHRONIC HEPATITIS B (CHB)Huang, W. C. / Peppa, D. / Easom, N. / Tan, X. Z. / Chang, C. / Trowsdale, J. / Gill, U. / Kennedy, P. / Maini, M. et al. | 2014
-
P150 INTERFERON-STIMULATED GENE 15, A PROVIRAL FACTOR FOR HEPATITIS C VIRUS, AND PROTEASOME SUBUNIT ALPHA TYPE-6 ARE INDUCED BY POLY(I:C) AND RECIPROCALLY AFFECT EACH OTHERBroering, R. / Trippler, M. / Lutterbeck, M. / Real, C. I. / Kleinehr, K. / Poggenpohl, L. / Gerken, G. / Schlaak, J. F. et al. | 2014
-
P148 DONOR SPECIFIC ANTIBODIES AGAINST HLA CLASS II AND C4D-POSITIVITY: RISK FACTORS FOR LIVER ALLOGRAFT FIBROSISIacob, S. / Cicinnati, V. R. / Lindemann, M. / Heinemann, F. M. / Radtke, A. / Kaiser, G. M. / Kabar, I. / Schmidt, H. H. / Baba, H. A. / Beckebaum, S. et al. | 2014
-
P151 HEPADNAVIRAL REPLICATION IN HBV-TRANSGENIC MICE LACKING THE SURFACE ANTIGEN IS ACCOMPANIED BY TOLL-LIKE RECEPTOR 3 MEDIATED INTERFERON RESPONSESReal, C. I. / Broering, R. / Jahn-Hofmann, K. / Ickenstein, L. / John, M. / Kleinehr, K. / Driftmann, S. / Lutterbeck, M. / Kemper, T. / Vornlocher, H. P. et al. | 2014
-
P154 VASCULAR ADHESION PROTEIN-1 ATTENUATES MYELOID DENDRITIC CELL FUNCTION AND MATURATION IN THE PRESENCE OF EXOGENOUS LPSWeston, C. J. / Curbishley, S. M. / Blahova, M. / Zimmermann, H. W. / Smith, D. J. / Adams, D. H. et al. | 2014
-
P170 INTRAHEPATIC QUASISPECIES HETEROGENEITY AS A PREDICTOR FOR VIROLOGICAL RELAPSE AFTER NUCLEOTIDE ANALOGUES WITHDRAWAL IN HBeAg POSITIVE CHRONIC HEPATITIS B PATIENTS: A PROSPECTIVE STUDYGan, Q. R. / Pan, C. / Lin, M. H. / Lin, R. S. / Li, Q. / Yao, L. F. / Zhang, D. Q. / Li, Q. G. / Chen, L. et al. | 2014
-
P214 SPECIFIC MUTATIONS (L5P; L7P; L15S) IN THE IMMUNODOMINANT EPITOPE HCV-NS3 (AA 1253–1272) AGAINST HLA-DQB1*0301, PROVOKE NON-RESPONSE TO ANTIVIRAL TREATMENT WITH PEGIFN/RBV IN PATIENTS WITH CHC-1de Rueda, P. M. / Quiles, R. / Gila, A. / Nevot, M. A. / Casado, J. / Carazo, A. / Álvarez, A. B. / Ruíz, S. J. / Gámez, J. A. / Castillero, E. J. et al. | 2014
-
P213 REGULATION OF THE AKT/MTOR PATHWAY BY METFORMIN IN HEPATOCELLULAR CARCINOMA DEVELOPMENT UPON HCV INFECTIONDel Campo, J. A. / García-Valdecasas, M. / Muntané, J. / Padillo, F. J. / Romero-Gómez, M. et al. | 2014
-
P268 CHRONIC INTERMITTENT HYPOXIA EXACERBATES ENDOTHELIAL DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASEHernandez-Guerra, M. / Gonzalez-Paredes, J. / Abrante, B. / Diaz-Flores, F. / Marcelino, R. / Hernandez-Camba, A. / Gonzalez, Y. / Fumero, C. / Quintero, E. et al. | 2014
-
P278 REPRESSION OF THE NUCLEAR RECEPTOR SMALL HETERODIMER PARTNER (SHP) IN NAFLD: GENE REGULATION BY TRANSCRIPTION FACTORS AND STEATOTIC DRUGSBenet, M. / Guzmán, C. / Pisonero, S. / Martínez-Chantar, M. L. / Sánchez-Campos, S. / Castell, J. V. / Jover, R. et al. | 2014
-
P302 METADOXINE SIGNIFICANTLY IMPROVES SURVIVAL IN ABIC CLASS B PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS WHEN ADDED TO PENTOXIFYLLINE OR PREDNISONEHiguera-de la Tijera, F. / Servin-Caamaño, A. I. / Serralde-Zuñiga, A. E. / Cruz-Herrera, J. / Pérez-Torres, E. / Abdo-Francis, J. M. / Pérez-Hernández, J. L. / Salas-Gordillo, F. et al. | 2014
-
P319 HYPOTHERMIA IN ACUTE LIVER FAILURE: A MULTI-CENTRE RETROSPECTIVE COHORT ANALYSIS (ITS ALRIGHT TO BE COOL)Karvellas, C. J. / Stravitz, R. T. / Battenhouse, H. / Durkalski, V. / Lee, W. M. / Schilsky, M. L. et al. | 2014
-
P372 APOPTOSIS INDUCED BY BILIRUBIN AND LITHOCHOLIC ACID IN HUMAN OSTEOBLASTS IS NEUTRALIZED BY URSODEOXYCHOLIC ACIDRuiz-Gaspà, S. / Dubreuil, M. / Guañabens, N. / Combalia, A. / Peris, P. / Monegal, A. / Pares, A. et al. | 2014
-
P387 REGULATORY T-CELL IMPAIRMENT IN AUTOIMMUNE LIVER DISEASE IS LINKED TO AN ABERRANTLY HIGH EXPRESSION OF CD127Liberal, R. / Grant, C. R. / Cardone, J. / Ma, Y. / Heneghan, M. A. / Mieli-Vergani, G. / Vergani, D. / Longhi, M. S. et al. | 2014
-
P414 ASSESSMENT OF THE CHANGE IN ESTIMATED GLOMERULAR FILTRATION RATES IN TELBIVUDINE- OR LAMIVUDINE-BASED TRERAPY IN PATIENTS WITH CHRONIC HEPATITIS BSun, J. / Cheng, J. / Chen, X. / Xie, Q. / Tan, D. / Wang, H. / Chen, S. / Yu, Y. / Tang, H. / Niu, J. et al. | 2014
-
P430 SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA: COMBINATION WITH SORAFENIB IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMESMa, M. X. / Adams, L. / Garas, G. / Macquillan, G. / Odea, M. / Samuelson, S. / Tibballs, J. / Mac Nicholas, R. et al. | 2014
-
P445 CLIF-SOFA SCORING SYSTEM ACCURATELY PREDICTS IMMINENT MORTALITY OF ACUTELY DECOMPENSATED PATIENTS WITH ALCOHOLIC CIRRHOSISLee, M. / Lee, J. H. / Yoon, J. H. / Oh, S. / Jang, Y. / Lee, W. / Lee, H. J. / Yoo, J. J. / Choi, W. M. / Cho, Y. Y. et al. | 2014
-
P451 COST EFFECTIVENESS OF RIFAXIMIN-a IN THE REDUCTION OF RECURRENCE OF OVERT HEPATIC ENCEPHALOPATHYPoole, C. D. / Conway, P. / Nanuwa, K. / Joseph, B. / Bannister, C. / Currie, C. J. et al. | 2014
-
P460 A METABOLOMIC PROFILE INCLUDING 5 LIPIDIC METABOLITES CORRELATES WITH DIAGNOSIS OF IDIOPATHIC PORTAL HYPERTENSIONSeijo, S. / Lozano, J. J. / Martínez-Chantar, M. L. / Miquel, R. / Berzigotti, A. / Turon, F. / Alonso, C. / Castro, A. / Mato, J. M. / Hernández-Gea, V. et al. | 2014
-
P477 VALUE-BASED OUTCOME INDICATORS IN LIVER CIRRHOSIS: VALIDATION IN A LARGE MULTICENTER STUDY (VBMH STUDY)Okolicsanyi, S. / Ciaccio, A. / Rota, M. / Gentiluomo, M. / Gemma, M. / Grisolia, A. / Cortesi, P. A. / Scalone, L. / Mantovani, L. / Pontisso, P. et al. | 2014
-
P496 OSTEOPONTIN IS A NEW NON-INVASIVE PARAMETER OF PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSISBruha, R. / Jachymova, M. / Petrtyl, J. / Vitek, L. / Urbanek, P. / Dvorak, K. et al. | 2014
-
P518 HEPATIC VENOUS PRESSURE GRADIENT, ASA CLASS AND TYPE OF SURGERY ARE PROGNOSTIC FACTORS OF EXTRA-HEPATIC SURGERY IN PATIENTS WITH CIRRHOSIS: A MULTI-CENTER PROSPECTIVE OBSERVATIONAL STUDYReverter, E. / Cirera, I. / Albillos, A. / Debernardi-Venon, W. / Abraldes, J. G. / Llop, E. / Flores, A. / Martínez-Palli, G. / Blasi, A. / Martinez, J. et al. | 2014
-
P517 EFFECTS OF SAPROPTERIN ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A BICENTRIC DOUBLE-BLIND PLACEBO CONTROLLED STUDYReverter, E. / Mesonero, F. / Seijo, S. / Martínez, J. / Abraldes, J. G. / Peñas, B. / Berzigotti, A. / Bosch, J. / Albillos, A. / García-Pagán, J. C. et al. | 2014
-
P525 FUNCTIONAL CAPACITY, RESPIRATORY MUSCLE STRENGTH, AND OXYGEN CONSUMPTION PREDICT MORTALITY IN PATIENTS WITH CIRRHOSISMarroni, C. A. / Galant, L. H. et al. | 2014
-
O12 RESTORATION OF HCV-SPECIFIC CD8+ T-CELL RESPONSES WITH INTERFERON-FREE TREATMENT OF HEPATITIS CMartin, B. / Hennecke, N. / Blum, H. E. / Kukolj, G. / Böcher, W. O. / Thimme, R. et al. | 2014
-
O26 NAFLD IS AN INDEPENDENT PREDICTOR OF EARLY CAROTID ATHEROSCLEROSIS: RESULTS FROM A LARGE TRANSVERSAL STUDY AND LONG-TERM FOLLOW-UP VALIDATION COHORTPais, R. / Giral, P. / Perazzo, H. / Khan, J. F. / Lebray, P. / Rosenbaum, D. / Munteanu, M. / Poynard, T. / Ratziu, V. et al. | 2014
-
O28 β7-INTEGRINS AND MADCAM-1 PLAY AN OPPOSING ROLE DURING THE DEVELOPMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)Drescher, H. K. / Schippers, A. / Erschfeld, S. / Noels, H. / Wagner, N. / Trautwein, C. / Streetz, K. / Kroy, D. C. et al. | 2014
-
O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMAZanetto, A. / Ferrarese, A. / Vitale, A. / Cillo, U. / Rodriguez, K. I. / Fadin, M. / Gavasso, S. / Radu, C. / Zerbinati, P. / Simioni, P. et al. | 2014
-
O72 PHASE 1–2 CLINICAL TRIAL IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS TREATED WITH BONE-MARROW DERIVED ENDOTHELIAL PROGENITOR CELLS: PRELIMINARY SAFETY AND EFFICACY ANALYSISDAvola, D. / Fernandez-Ruiz, V. / Carmona-Torre, F. / Mendez, M. / Prosper, F. / Andreu, E. / Herrero, J. I. / Iñarrairaegui, M. / Fuertes, C. / Bilbao, J. I. et al. | 2014
-
O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188)Deuffic-Burban, S. / Schwarzinger, M. / Obach, D. / Mallet, V. / Pol, S. / Pageaux, G. P. / Canva, V. / Deltenre, P. / Roudot-Thoraval, F. / Larrey, D. et al. | 2014
-
O98 T-CELL RE-DIRECTION AGAINST GLYPICAN-3 FOR IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC)Dargel, C. / Bassani-Sternberg, M. / Wilde, S. / Dossinger, G. / Kerbs, K. / Schiemann, M. / Schendel, D. / Busch, D. H. / Mann, M. / Protzer, U. et al. | 2014
-
O109 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-2 STUDYAfdhal, N. / Reddy, R. K. / Pockros, P. / Di Bisceglie, A. M. / Arora, S. / Yang, J. C. / Dvory-Sobol, H. / Zhu, Y. / Pang, P. S. / Symonds, W. T. et al. | 2014
-
O113 COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDYSu, W. W. / Hsu, C. W. / Lee, C. M. / Peng, C. Y. / Chuang, W. L. / Kao, J. H. / Chien, R. N. / Chu, H. C. / Huang, Y. H. / Liaw, Y. F. et al. | 2014
-
O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASEChan, H. L. / Ahn, S. H. / Chang, T. T. / Peng, C. Y. / Wong, D. / Coffin, C. S. / Lim, S. G. / Chen, P. J. / Janssen, H. L. / Marcellin, P. et al. | 2014
-
O138 PHASE 1 CLINICAL TRIAL OF LIVER DIRECTED GENE THERAPY WITH rAAV5-PBGD IN ACUTE INTERMITTENT PORPHYRIA: PRELIMINARY SAFETY DATADAvola, D. / López-Franco, E. / Harper, P. / Fontanellas, A. / Grosios, N. / Sangro, B. / Henrichson, A. / Salmon, F. / Fuertes, C. / Abecia, S. et al. | 2014
-
O152 THE SPLICING FACTOR SLU7 IS ESSENTIAL FOR THE PRESERVATION OF LIVER DIFFERENTIATION, METABOLIC FUNCTION AND QUIESCENCEElizalde, M. / Urtasun, R. / Azkona, M. / Latasa, M. U. / Goñi, S. / Garcia-Irigoyen, O. / Uriarte, I. / Segura, V. / Collantes, M. / Di Scala, M. et al. | 2014
-
P4 SERUM GALECTIN-3 LEVELS IN PATIENTS WITH LIVER FAILURE AND ITS CORRELATION WITH PROGNOSISYang, Y. F. / Zhen, Y. S. / Zhang, L. / Shi, D. Y. / Xiao, L. Y. et al. | 2014
-
P1065 EPIDEMIOLOGY OF HBV INFECTION IN A COHORT OF UGANDAN HIV-INFECTED PATIENTS AND RATE AND PATTERN OF LAMIVUDINE-RESISTANT HBV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPYCalisti, G. / Muhindo, R. / Boum, Y. / Wilson, L. A. / Foster, G. M. / Geretti, A. M. / Bhagani, S. et al. | 2014
-
P1074 THE EFFECT OF LONG-TERM NUCLEOSIDE/TIDE ANALOGUE TREATMENT ON INTRAHEPATIC HBVDNA AND COVALENTLY CLOSED CIRCULAR DNA IN CHRONIC HEPATITIS B PATIENTSWong, D. K. / Lai, C. L. / Ip, P. / Kopaniszen, M. / Seto, W. K. / Fung, J. / Huang, F. Y. / Wu, R. / Cheng, C. / Ngai, V. et al. | 2014
-
P1080 TREATMENT CESSATION IS SAFE AND EFFECTIVE AFTER PROLONGED SUPPRESSION WITH NUCLEOSIDES/NUCLEOTIDES IN HBV E-ANTIGEN NEGATIVE, NON-CIRRHOTIC PATIENTSPatwardhan, V. / Sengupta, N. / Bonder, A. / Lau, D. / Afdhal, N. et al. | 2014
-
P1105 HEPATITIS C TREATMENT IN A DIFFICULT, GEOGRAPHICALLY DISPERSED POPULATION: ATTENTION TO DETAIL IS KEYWeston, N. / Kay, B. / Mitchell, J. et al. | 2014
-
P1110 HIGH-RESOLUTION HCV SUBTYPING USING MASSIVE SEQUENCING AND PHYLOGENY, OPTIMAL ALTERNATIVE TO CURRENT METHODSQuer, J. / Gregori, J. / Rodríguez-Frias, F. / Buti, M. / Madejon, A. / Perez del Pulgar, S. / Garcia-Cehic, D. / Casillas, R. / Blasi, M. / Homs, M. et al. | 2014
-
P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALSZeuzem, S. / Jensen, D. M. / Carvalho, A. / Diago, M. / Feinman, S. V. / Kowdley, K. V. / Kao, J. H. / Maevskaya, M. / Negro, F. / Mantry, P. et al. | 2014
-
P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALSZeuzem, S. / Demasi, R. / Foster, G. R. / Buti, M. / Baldini, A. / Luo, D. / Witek, J. / Rizzetto, M. et al. | 2014
-
P1127 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION IN TREATMENT-NAIVE EUROPEAN PATIENTS IN THE QUEST-1 AND QUEST-2 PHASE III TRIALSFoster, G. R. / Jacobson, I. M. / Dore, G. J. / Fried, M. / Manns, M. / Marcellin, P. / Poordad, F. / de Araujo, E. S. / Peeters, M. / Lenz, O. et al. | 2014
-
P1143 APPLICABILITY OF TRIPLE THERAPY IN CIRRHOTIC POPULATION: VALIDATION OF CUPIC DATAVinaixa, C. / Satorres, C. / Garcia, M. / Benlloch, S. / Aguilera, V. / Rubin, A. / Prieto, M. / Berenguer, M. et al. | 2014
-
P1151 DECISION-MAKING IN (RE-)STARTING HEPATITIS C TREATMENT AT THE DAWN OF AN INTERFERON-FREE TREATMENT ERAKuenzler/Heule, P. / Semela, D. et al. | 2014
-
P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICECabezas Gonzalez, J. / Diago, M. / Berenguer, M. / Broquetas, T. / Serra, M. / Morillas, R. / García-Samaniego, J. / Calleja, J. L. / Sánchez, J. J. / Lens, S. et al. | 2014
-
P1217 EVALUATION OF PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO INTERFERON THERAPY AND HEPATIC PROGENITOR CELLS (HPCS) IN CHRONIC HEPATITIS C VIRUS (HCV) INFECTED PATIENTSGhweil, A. A. / Galal, G. M. / Moustafa, E. F. / Zaghlol, A. M. / Muhammad, E. M. / Kasem, A. M. et al. | 2014
-
P1244 FAVORABLE PRECLINICAL PROFILE OF IDX21437, A NOVEL URIDINE NUCLEOTIDE PRODRUG, FOR USE IN A DIRECT-ACTING ANTIVIRAL (DAA) REGIMEN FOR HCVGupta, K. / Seifer, M. / Serra, I. / Rashidzadeh, H. / Luo, S. / La Colla, M. / Pan-Zhou, X. R. / Chapron, C. / Hernandez-Santiago, B. / Mayes, B. et al. | 2014
-
P1253 ACTIVATION OF PPAR-γ SIGNALING AS A NOVEL TARGET TO LIMIT NF-κB-DEPENDENT INFLAMMATION IN CYSTIC FIBROSIS BILIARY EPITHELIUMScirpo, R. / Fiorotto, R. / Fabris, L. / Strazzabosco, M. et al. | 2014
-
P1274 COSTS OF CIRRHOTIC PATIENTS ON THE WAITING LIST FOR LIVER TRANSPLANT: IMPACT OF DISEASE SEVERITY AND TIME ON LISTTurri, J. A. / Haddad, L. B. / Andraus, W. / Diniz, M. A. / DAlbuquerque, L. A. et al. | 2014
-
P1277 VISITING A PRIMARY CARE PHYSICIAN AMONG PERSONS WHO INJECT DRUGS ATTENDING SYRINGE EXCHANGE PROGRAMS: COUPLING STRATEGIES TO OPTIMIZE HCV PREVENTIONArtenie, A. A. / Bruneau, J. / Zang, G. / Bamvita, J. M. / Lévesque, A. / Jutras-Aswad, D. / Daniel, M. / Roy, . et al. | 2014
-
P1290 EARLY VIROLOGIC RESPONSES AND ADVERSE EVENTS FROM THE COMPARATIVE ASSESSMENT OF EFFECTIVENESS OF ANTIVIRAL THERAPIES IN HEPATITIS C STUDY (CMPASS)Buti, M. / Mauss, S. / Ryder, S. / Isakov, V. / Paraná, R. / Kalsekar, A. / Litalien, G. / Sapra, S. et al. | 2014
-
P1296 HEPATOLOGY E-CONSULTATION: THE WAY FORWARD? A REVIEW OF OUR INITIAL EXPERIENCE AND COST ANALYSISMoreea, S. / Southern, P. B. / Connolly, J. / Appleby, V. J. et al. | 2014
-
P1297 A NOVEL NURSE LED MODEL OF TREATMENT DOES NOT INCREASE TREATMENT RATES IN INJECTION DRUG USERS WITH HEPATITIS C VIRUSLewis, H. / Kunkel, J. / Wilkinson, M. / Foster, G. R. et al. | 2014